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Abstract
Higher-order chromatin organization in cell nucleus is mysterious. Microscopy and highthroughput sequencing technologies have been applied to reveal the connections between
genome structure and gene transcription, which is the main topic of my thesis. Higher-order
chromatin organization differs across cell types and species, giving an insight into disease
genesis and tumorigenesis. Despite an enormous progress has been made recently in epigenomic
study, lots of things remain unknown.
My dissertation reviews the current understanding of epigenomics, characterizes
chromatin interaction in mammalian cells using different technologies, investigates chromatin
reorganization in breast cancer cells, analyzes integrated genomic and epigenomic data in breast
cancer metastasis and discusses results and future directions.
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Chapter 1: Introduction
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Chapter 1
1.1 Overview
Chromatin interaction is recently studied to reveal the molecular mechanisms of
transcription regulation and disease development in mammalian cells by using high-throughput
sequencing and microscopic imaging technologies. The investigation in chromatin interaction
might provide novel insights into cancer therapeutics and precision medicine.
In this chapter, I will review the current understanding of chromatin interaction and
genome organization, the molecular mechanism of transcription regulation by DNA elements in
different cell types including normal and cancer cells and the cutting-edge technologies in
studying chromatin biology. Then I will outline the hypothesis and specific aims of my thesis
projects.
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1.2 Literature Review
Cell nucleus contains the whole genome, stores information and decides cell fate. The
mammalian genome comprises of meters of DNA. How the DNA is organized in the tens of
microns cell nucleus is not fully known. The chromatin structure is dynamic over time to deliver
accurate command for cell function. Therefore, the disorder of chromatin reorganization could
lead to gene dysregulation and cellular abnormalities, which is often an implication of diseases.
I will review studies in chromatin organization form different perspectives and its
implications in cancer development especially breast cancer.
The genome structure in three-dimension
How chromatin is organized in eukaryotic cell nucleus is a historically mysterious
question. It is known DNA is packed in different levels to allow meters long linear DNA
condensed in micrometers nucleus. In 1970s, the repeating “beads on string” structure was
observed by electron microscopy and nucleosomes were stated as the first level structural and
functional unit for chromatin compaction1–5 (Figure 1.1). It was firstly proposed that the
nucleosome contained around 200 bp of DNA2,6, but later it was found more accurately by X-ray
crystal structure analysis about 146 bp of DNA were wrapped around the histone octamer to
form nucleosomes7 (Figure 1.2), which were connected by dozens of bp of linker DNA,
appearing as a “beads on string” structure8. The 10 nm DNA fiber is then folded into higherorder chromatin structures that allows further compaction fitting into the nucleus. The higherorder genome structure is elusive for tens of years. Although the 30 nm chromatin fiber structure
was observed and proposed to be the next level structure of 10 nm fiber5,9–11, it remains
debatable since it was only observed in vitro8,12,13. Even less is known about the higher-order
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structure other than the putative 30 nm fiber. Therefore, more advanced technologies for in vivo
analysis are highly desired to decipher the higher-order genome structure.

Figure 1.1 The organization of DNA within
the chromatin structure
The lowest level of organization is the
nucleosome, in which two superhelical turns of
DNA are wound around the outside of a histone
octamer. Nucleosomes are connected to one
another by short stretches of linker DNA.
The figure and legend are cited from (Luger et
al., 1997)
8

Figure 1.2 Nucleosome core particle
Ribbon traces for the 146-bp DNA
phosphodiester backbones (brown and
turquoise) and eight histone protein main
chains (blue: H3; green: H4; yellow: H2A; red:
H2B). The views are down the DNA superhelix
axis for the left particle and perpendicular to it
for the right particle. For both particles, the
pseudo-twofold axis is aligned vertically with
the DNA center at the top.

The figure and legend are cited from
(Felsenfeld and Groudine, 2003)
7

With the development and application of DNA in situ hybridization (ISH) and
fluorescence in situ hybridization (FISH) combined with microscopy, the whole chromosomes
were managed to be painted and chromosome territories (CTs) (Figure 1.3) were clearly
observed14–16 proving the DNA fibers from different chromosomes are not intermingling like
spaghetti but compartmentalized into discrete domains in interphase nucleus. After then, this
chromosome painting technology was applied to study chromatin organization at chromosomal
level in different cell types. The major goal is to examine the non-randomness of CT
arrangement and identify its connections to gene transcription and cellular function. For example,
the studies of gene-rich (Chromosome (Chr) 19, Chr17, Chr11) and gene-poor (Chr18, Chr13,
ChrY) chromosomes indicated gene-rich CTs were in more irregular shape (ellipsoid-like) than
4
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gene-poor CTs17. Another example is the CTs of Chr18 and Chr19 were delineated and
compared in lymphoblastoid cells across primate species. It was consistently found in all the
primate species examined Chr18 were positioned closer to nuclear periphery, while Chr19 was
more toward the centroid of the nucleus18, implying a radial positioning of genes in cell nucleus
for transcription regulation, which is consistent with the finding that nuclear lamina (Figure 1.3)
or lamina-associated domains (LADs) at nuclear periphery are more heterochromatic and
associated with transcriptional repression19. Furthermore, the relative position of certain gene
and the CT can be transcription relevant20. During the differentiation process of mouse
embryonic stem cells (ESCs), it was observed Hoxb genes got activated by extruding out of the
CT, while stayed in the CT before activation21. Broadly, it has been suggested transcriptionally
active genes are more often found on the periphery of CT20,22. There then came a speculation of
the inter-chromosomal domain (ICD) that the CT boundaries and the space between adjacent
CTs are decondensed and preferentially transcriptionally active with RNA transcripts released
directly23; and it was reported ICD can facilitate information exchange and cooperation of gene
regulation between chromosomes24. However, it does not mean gene cannot transcribe within
CTs25.
Recently, high-throughput next-generation sequencing technology provided an
advantageous platform for genome structure characterization. The most hotly used are chromatin
immunoprecipitation sequencing (ChIP-seq) of histone marks, DNase hypersensitive sites (DHS)
and transposase-accessible chromatin using sequencing (ATAC-seq)26 to examine chromatin
state and accessibility; high-throughput chromosome conformation capture (Hi-C)27 and
chromatin interaction analysis using pair-end tag sequencing (ChIA-PET)28 to genome-widely
map long-range chromatin interaction (usually from several kilobases to hundreds of kilobases)
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that can be reconstructed and remodeled to simulate the whole picture of the genome. Chromatin
state or accessibility is an important indicator of the activity of gene or DNA element. For
instances, Histone 3 lysine 27 acetylation (H3K27ac) distinguishes active enhancers from poised
enhancers29, while Histone 3 lysine 4 trimethylation (H3K4me3) is enriched in active
promoters30. However, it does not reflect the 3D structure of the genome as it cannot detect the
connectivity of individual chromatin sites. Chromatin interactions suggests a looping structure
which means two chromatin loci can physically come together even they are far away in linear
genomic distance (Figure 1.3). Chromatin interaction is usually mediated by protein factors,
either transcriptionally or structurally related. Transcription-associated chromatin interaction
may form transcription factories to efficiently facilitate gene transcription31,32 (Figure 1.3).
Overall, the interactions can be promoter-promoter, distal DNA element-distal DNA element or
promoter-distal DNA element31,33. Of them, enhancer-promoter is the most well-studied type of
interaction. Recently, the concept of super-enhancer was established as a region composing
multiple enhancers involved in cellular identity bound by a series of master transcription
factors34. Theoretically, by reconstructing and remodeling the genome-wide interactions, we will
be able to depict any compartment and even the whole picture of the genome35,36. According to
the chromatin interaction frequency of cell population, a structure with mega bases of DNA was
defined as topologically associating domain (TAD) (Figure 1.3) that is conserved across cell
types in a given organism37,38, but may differ between cell lineages36,39. Within TAD, chromatin
contacts occured remarkably more frequent than those outside40. Extensive studies have found
TAD plays important roles in transcription regulation and DNA replication41,42.
Similar to TAD, insulated neighborhood was proposed to be the mechanistic basis of
TAD. Insulated neighborhood is defined as a CCCTC-binding factor (CTCF)-CTCF confined
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chromatin loop, with at least one gene inside, CTCF binding at both anchor sites, co-bound by
cohesin. It provides an insulated region for specific enhancer-promoter interaction and
transcription. Based on the definition, at least 50% of the TADs are insulated neighborhoods in
mammalian cells43.
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Figure 1.3 Different Levels of
Genome Organization
From top to bottom: Level 1:
Chromosomes occupy distinct
subregions of the nucleus known as
chromosome territories (CTs).
Individual chromosomes are
indicated by different colors. Level
2: Transcriptionally inactive regions
are enriched at the nuclear
periphery, where they contact the
nuclear lamina (red). Actively
transcribed genes often colocalize at
RNA polymerase II transcription
factories (yellow). These and other
instances of colocalization between
regions with similar transcriptional
activity may provide the physical
basis for the observations of A and
B compartments in C data. Level 3:
Topological domains, or
topologically associating domains
(TADs), are regions of frequent
local interactions separated by
boundaries across which interactions
are less frequent. CTCF binding
sites and other sequence features are
enriched at TAD boundaries. Note
that CTCF also binds within TADs.
Cohesin is often present at TAD
boundaries, although it is not shown
here. Level 4: Transcriptional
regulation depends on long-range
interactions between cis-regulatory
elements such as enhancers (light
red) and promoters (light yellow).
These cis-regulatory interactions are
facilitated by proteins including
transcription factors (TFs; blue),
cofactors such as Mediator (Med;
red) and Cohesin (purple ring), and
RNA polymerase II (Pol II; yellow).
The figure and legend are cited from
(Gorkin et al., 2014)
128
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Methods to study chromatin organization
The most often used methods to investigate chromatin organization are DNA FISH
combined with microscopy, high-throughput sequencing combined with molecular library
construction and genome editing including clustered regularly interspaced short palindromic
repeats (CRISPR)44 or transcription activator-like effector nucleases (TALEN)45 systems.
FISH assays have been applied to stain interest chromatin regions, sizing from dozens of
kilobases to the whole chromosome, followed by microscopic imaging. The two most critical
factors affecting staining capabilities and imaging qualities are DNA probes and microscopic
resolution. Probes for CT and whole chromosome are already well-established. However, to
study ultrastructure such as chromatin interaction, which usually spans hundreds of kilobases of
DNA with two interacting loci of only several kilobase length at the anchors, regulator bacterial
artificial chromosome (BAC) originated probes can hardly fulfill the requirement as each BAC
probe stains about 200 kb DNA lacking accuracy and specificity. To overcome this shortage of
regular probes, oligopaints have been developed with advantages in staining accuracy, specificity
and flexibility46. Basically, oligopaints can be designed to stain any desired chromatin regions by
pooling microarray probes. It has been successfully applied to distinguish homologous
chromosomes47 and evaluate chromatin state48. Regarding microscopy technologies, the trend is
to bypass the diffraction barrier, break the resolution limit of 200 nm inherent in conventional
microscopy, and achieve super resolution. Though electron microcopy has higher resolution than
conventional microscopy, it is not easy to apply in studying chromatin structure due to the
limitation of labeling. I will only review super-resolution light microcopy in this chapter. Of all
the super-resolution microscopic technologies, there are three main methods that have been
widely used: structural illumination microscopy (SIM)49, stimulated emission depletion
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(STED)50 and photoactivated localization microscopy/stochastic optical reconstruction
microscopy (PALM/STORM)51,52. Beyond the basic two-dimension (2D) imaging, 3D SIM53,
3D STED54, 3D STORM55–57 and interferometric PALM (iPALM)58 have been developed to be
more powerful for 3D genome study47,59–62. Recently, these super-resolution imaging
technologies were largely utilized in investigating chromatin structure. Epigenetic states63,64 and
TAD65 inferred by sequencing data were imaged and analyzed by STORM, validating the
predictions made from sequencing data. Whereas, the biggest limitation of imaging-based
methods is low-throughput that only a few cells can be imaged at a time.
Next-generation sequencing provided an efficient platform for genome structure study
with cell populations (Figure 1.4). As mentioned previously, ChIP-seq with histone mark
antibodies are very commonly used to investigate the distribution of certain chromatin state,
active, inactive or poised. Similarly, DNase and ATAC-seq are also used to identify chromatin
state, but can only classify it into two states, either open (transcriptionally active) or closed
(transcriptionally inactive). More importantly, proximity ligation-based technologies came out to
capture chromatin contacts and map its 3D organization66. Chronologically, chromosome
conformation capture (3C)67 was firstly developed to capture one-to-one interactions. After then,
circular chromosome conformation capture (4C)68 and chromosome conformation capture carbon
copy (5C)69 came out at about the same time to identify one-to-many and many-to-many
chromatin contacts, respectively. In 2009, Hi-C27 and ChIA-PET28 were firstly reported to
capture chromatin interactions genome-widely in an all-to-all manner. The differences between
Hi-C and ChIA-PET is that Hi-C captures all the chromatin interactions while ChIA-PET
selectively captures a subset of interactions mediated by interest protein factors. Both Hi-C and
ChIA-PET have nonnegligible shortcomings: Hi-C needs billions of sequencing reads and ChIA-
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PET requires millions of cells. To overcome these difficulties, novel technologies have been
developed recently such as HiChIP70, Capture Hi-C71 and others.

Figure 1.4 Overview of 3C-derived methods
An overview of the 3C-derived methods that are discussed is given. The horizontal panel shows the
cross-linking, digestion, and ligation steps common to all of the ‘‘C’’ methods. The vertical panels
indicate the steps that are specific to separate methods.
The figure and legend are cited from (Wit and Laat, 2012)
66
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Besides DNA FISH imaging and genome sequencing, genome editing tools such as
TALEN and CRISPR44 have also be used to validate chromatin interaction inferred by
sequencing data. Specifically, multigene co-transcription, enhancer regulation on gene promoter
and CTCF mediated repressive chromatin loop43,72,73 were validated functionally using
TALEN74,75 and CRISPR/Cas976,77 for genetic editing. More interestingly, other than genetic
editing, CRISPR/dCas9 can be applied in epigenetic modification on target chromatin site, in
order to modulate gene transcription78. In the other way around, functional CRISPR screening
enables to map chromatin interaction and identify enhancers79–83, providing a novel insight into
genome structure investigation.
Key regulators of genome structure
Genome architecture is established with known and unknown factors involved. The most
well-studied protein factors driving chromatin organization are CTCF, cohesion and RNA
polymerase II (RNAPII). Recently, Yin Yang 1 (YY1) was reported to regulate enhancerpromoter interaction. In addition, some long non-coding RNA (lncRNA) such as X-inactive
specific transcript (Xist) and functional intergenic repeating RNA element (Firre) also play
important roles in genome structure conformation.
CTCF is a highly conserved protein from fly to human. 3D genome studies found CFCF
is a key genome organizer that mediates chromatin contacts, bridging the gap between the
working mechanism and its contradictorily diverse functions. As a gene activator, CTCF can
tether promoters with their enhancers or other promoters, forming a transcription complex to
promote gene expression33,84,85. As an insulator, CTCF was observed to enrich at the boundaries
of TAD36,37, demarcating the TADs from interacting with each other, thus, inhibited information
exchange between enhancers and promoters to repress gene transcription. It was proved by
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interrupting the TAD boundary, genes expressed ectopically43,86,87. Furthermore, ChIA-PET
analysis showed CTCF binding motif orientation is related to transcription35, connecting delicate
CTCF positioning with gene activity.
Cohesin is another important architectural regulator functioning similarly with CTCF. It
is a protein complex composed of subunits Smc1A, Smc3, Rad21 and Stag1/2. Cohesin
colocalize heavily with CTCF locating at the boundaries of TAD37 and mediating chromatin
interaction associated with gene activation or repression. However, cohesin can bind chromatin
site independently of CTCF. For example, cohesin was found to interact with Mediator to
contribute to chromatin looping and co-occupy active gene promoters and enhancers in ESCs88.
Despite the similar functions as genome organizers, cohesin and CTCF affect chromatin
organization differentially. A general loss of local chromatin interactions by disrupting cohesin
was observed, but the TADs remain intact. Whereas, the depletion of CTCF not only reduced
interactions within TADs but also increased interactions across TADs89. Furthermore, distinct
groups of genes become dysregulated upon depletion of cohesin and CTCF89.
RNAPII is an essential subunit of transcription factors for gene transcription in
eukaryotic cells. ChIA-PET analysis showed RNAPII mediates transcriptionally related
chromatin interaction. In most of the cases, RNAPII mediated chromatin interactions are shorter
than and residing in CTCF/cohesin mediated ones35. It is often used to identify potential
enhancers and examine enhancer reorganization by studying RNAPII mediated chromatin loops.
YY1 is a transcription factor in mammalian cells90–92. Only recently, YY1 was found to
be involved in chromatin interactions between enhancers and promoters across cell types93.
Xist is a well-known lncRNA functioning to inactivate one of the X chromosomes in
female cells. Xist express and spread over in cis to silence the whole X chromosome. It is still
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not clear how Xist inactivates X chromosome. Comprehensive Xist interactome study revealed
Xist repelled architectural factors such as cohesin from the inactive X chromosome (Xi),
directing a specific chromosome conformation of Xi94.
Firre is a structural component of nuclear matrix expressed in X chromosome. However,
its role in shaping genome structure is poorly understood. Firre was found to express locally at X
chromosome but interact in trans with genes at autosomes95, suggesting a modulation
mechanism across chromosomes. Additionally, by ChIA-PET analysis, super long chromatin
loops projected out from Firre genomic locus to both sides only at active X chromosome (Xa) in
GM12878 cells35, consistent with the knowledge that Xi and Xa are in different chromosome
conformation, implying the contribution of Firre.
Chromatin reorganization in diseases
Higher-order chromatin organization is one of the critical factors driving gene
transcription, which is different across cell types and species. It is natural to assume chromatin is
reorganized in disease cells. Studying disease-associated genome structures reveals fundamental
mechanisms underlying disease genesis, providing insights into therapeutics. I will review the
reorganization in diseases from different levels of CT, TAD, insulated neighborhood and
enhancer-promoter interaction.
In immune-deficiency centromeric instability facial anomalies (ICF) syndrome, PAR2
genes were reorganized to localize toward the outside of Xi and Chromosome Y (ChrY) CTs,
accompanying with loss of DNA methylation on Xi96. This is a direct reflection of connections
between CT reorganization and disease. Indirectly, translocations prefers to occur between
neighboring chromosomes instead of chromosomes that are far away from each other97,98. Hence,
translocation-associated disease is attributed to the organization of CTs to some degree.
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TAD is a highly self-interacting chromatin domain discussed previously. It maintains
frequent interactions inside these discrete compartments but prevents interactions across them.
Disruption of TADs can cause ectopic gene expression and diseases. For instance, the altered
chromatin structure at WNT6/IHH/EPHA4/PAX3 locus spanned by TADs is the cause of a
distinct human limb malformation. By disrupting the TAD boundary in normal mice, enhancers
and promoters ectopically rewired across TADs, resulting pathogenic phenotypes, suggesting a
molecular mechanism for limb malformation86. Another example is about T-cell acute
lymphoblastic leukemia (T-ALL). The perturbation of insulated neighborhood boundaries in
non-malignant cell activated T-ALL proto-oncogenes73. Somatic mutations, DNA
hypermethylation and structural variations at the anchor sites of insulated neighborhoods were
found to contribute to oncogenesis73,99,100.
Enhancer-promoter interaction is the most straightforward structure regulating gene
transcription. Enhancer malfunction could be the cause of diseases. Genetic or epigenetic
variations such as point mutations101 and aberrant methylation102,103 on enhancers were found to
contribute to cancer development and tumor progression. In colorectal cancer71 and breast
cancer104, enhancer arrangements were observed changed compared with normal cells. A region
containing a cluster of enhancers occupied by Mediator and other master transcription factors
was found to suggest cellular identify and defined as super-enhancer34. Super-enhancers were
widely studied in a variety of diseases and cancers such as lymphoma105,106, myeloma107 and TALL108. The acquisition of super-enhancers at oncogenes during the process of tumor
development could be the driver pathogenesis109.

15

Dissertation

Jacqueline Jufen Zhu

New insights into genome structure
Despite higher-order genome structure has been studied for about half a century, lots of
unknown remains.
It is hard to ignore that the limitations of current technologies stopping us from diving
deeper into the genome structure. Though DNA probing and imaging allows us to visualize the
chromatin organization directly, the resolution is relatively low. We can hardly handle to resolve
the DNA arrangement at kilobase level, not to say base level. The advantage of sequencing
methods is that it gives a better resolution than imaging. However, it requires a relatively large
number of cells. What we have acquired from sequencing data is an averaged information but not
accurate for each cell individual, which ignored heterogeneity across single cells.
Many studies focused on those key regulators on genome organization, but may
overestimate their function. As Denes Hnisz reviewed110, TADs and gene transcription inside
were not affected upon CTCF depletion by some studies, suggesting gene activation or
repression play important roles in genome arrangement in CTCF-independent manner. This
debated observation suggested the key regulators may not be truly “key” at all times but only
under particular circumstances.
An interesting argument is whether the genome structure is the cause or consequence of
gene transcription, or both. Based on current knowledge, it seems the answer is both. It is like a
circuit, the arrangement of the genome somehow determines the gene transcription, vice versa,
the transcribed gene functions to further shape the genome structure, till an internal balance
achieved. The balance can be broken by operational mistakes such as genetic mutations or
external stimuli. The cell will search to re-achieve another round of balance, till die.
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1.3 Hypothesis and Specific Aims
Project 1 Visualization of chromatin loop in human cells
How meters long chromatin is packed in micrometer-scale cell nucleus is mysterious.
The 3D structure of the genome is of fundamental importance for gene regulation and cellular
function. Methods to study 3D genome include molecular biology tools combined with next
generation sequencing and DNA staining combined with microscopic imaging. Regarding
sequencing, ChIA-PET and Hi-C technologies are most often used to capture higher-order
genome organization in kilo base resolution. Chromatin imaging can directly visualize genome
positioning using DNA FISH followed by microscopy.
Recent studies in genomics based on sequencing technologies inferred the very basic
functional chromatin folding structures known as chromatin loop. Long-range chromatin
interactions take place in nuclei are often mediated by protein factors at the loop anchor loci.
Due to theoretical and technical limitation of conventional microscope, the chromatin loop
cannot be resolved. To prove the existence of chromatin loop and elucidate its finer structure,
super-resolution microscopy is a powerful technology to be applied. iPALM is one of the most
well-established super-resolution microscopies that can resolve chromatin 3D structure at single
molecule level.
Hypothesis/Rational
Hi-C and ChIA-PET contact map data showed chromatin loops at various genomic loci
and length scales. After examining the whole genome, the target chromatin loop region was
selected at chromosome 14, which contains a high frequency loop that is about 13kb long and
mediated by both CTCF and RNAPII in GM12878 cells. Super-resolution microscopy such as
STORM has been recently used to image functional chromatin domains TAD and epigenetic
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states63,65. iPALM can achieve even higher resolution than STORM axially, which makes it
promising to resolve finer genome structures such as chromatin loop. By visualizing the target
chromatin loop, I expected to see a major looping structure inferred ChIA-PET and Hi-C data.
Possibly, there could be more complex structures beside the major loop.
Specific Aim
Aim Super-resolution imaging of a distinct chromatin loop in human lymphoblastoid cells.
I applied super-resolution microscopy iPALM to image a distinct chromatin loop inferred by
ChIA-PET in human lymphoblastoid GM12878 cells. I then processed the images for 3D
modeling and compared it with genomic data for evaluation.

Project 2 Identification of metastasis-associated chromatin interaction and gene
network
Beyond studying chromatin interaction in normal cells, we also aim to investigate
chromatin interaction and genome structures in breast cancer cells and identify metastasisassociated structures. Implied by connections between DNA elements, we can identify novel
genes and investigate the underlying molecular mechanisms in diseases and cancer.
Breast cancer lethality is primarily due to tumor metastasis to other organs such as the
lungs, liver and brain. Despite this, relatively little is understood about the etiology and
molecular mechanism of metastasis. Although previous works have identified genes whose
dysregulation is likely to be involved in metastasis111–119, more needs to be studied in a
comprehensive way.
One promising lead comes from the aspect of DNA element regulation on transcription. It
has been shown that chromatin interactions between gene promoters and distal enhancers can
regulate gene expression and establish cellular identity, the disruptions in which can lead to
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disease states31,86,120. By analyzing the global transcription and chromatin interaction in three
mouse mammary tumor-derived cell lines (4T1, 4T07 and 67NR) that vary in metastatic
potential121,122 although derived from the same tumor, we can identify metastasis-associated
genes and their regulatory elements. Further exploration on the functional consequences by
disrupting specific interactions using a genome-editing approach will provide more evidences to
prove the role of the regulatory elements.
By integrating polymorphic differences in mouse strains with differing metastatic
capacities with chromatin accessibility and interaction information to investigate the metastatic
cascade, we are able to identify genes involved in disseminated cell to metastatic lesion. By
implementing pathway analysis and validation, it will provide novel insights into the mechanism
of metastatic colonization for potential clinical intervention.
Specific Aim
Aim 1 Investigation of enhancer regulation on metastasis by chromatin interaction in
mouse cells lines. This aim is to interrogate enhancer regulation on metastasis associated genes
by characterizing genome-wide transcription and chromatin interaction combined with genome
editing validation.
Aim 1a Profiling transcription, chromatin accessibility and chromatin interaction of a
series of mouse cell lines. With 4T1, 4T07 and 67NR cells, I profiled the gene transcription by
RNA-Seq, characterized chromatin accessibility by benzonase-accessible chromatin (BACh)
analysis, and mapped chromatin interactions by ChIA-PET, specifically examining interactions
mediated by RNAPII.
Hypothesis/Rationale: I used a mouse cell model, a series of cell lines 4T1, 4T07 and 67NR
derived from the same spontaneous mammary tumor of BALB/c mouse that show various
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degrees of metastatic potential from high to low123. RNA-seq, BACh and ChIA-PET analysis
gave us a very comprehensive view of all the three cell lines to study metastasis, given the
hypothesis of chromatin reorganization leading cancer metastasis.
Aim 1b Identification of metastasis-associated transcription and chromatin interaction. By
comparative analysis of datasets from Aim 1a for the three cell lines, I identified differential
expressed genes especially 4T1 up-regulated genes that are most likely metastasis associated.
Combining the identified genes with BACh and ChIA-PET data, I further identified chromatin
interactions between potential enhancers and gene promoters associated in metastasis in 4T1
cells.
Hypothesis/Rationale: With the differences of metastatic predispositions in 4T1, 4T07 and
67NR cells though from the same tumor, comparative analysis of their transcription, chromatin
accessibility and chromatin interaction reveal the higher-order regulatory mechanism for gene
transcription.
Aim 1c Validation of enhancer function in metastasis. Informed by the results from the Aim
1b, I disrupted the target chromatin interactions by knocking out the enhancer in metastatic 4T1
cells using CRISPR/Cas9 system to interrogate transcriptional and phenotypic changes in cell
adhesion and migration.
Hypothesis/Rationale: Informed by the results from Aim 1a and Aim 1b, enhancers are
candidate targets in transcription regulation. Thus, it is meaningful to validate enhancer function
by knocking it out to interrupt the interaction with target genes. In 4T1 cells, knocking out the
identified enhancer from Aim 1b could suppress target gene expression and metastatic
phenotypes.
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Aim 2 Identification of a core metastasis susceptibility network by integrating genetic,
epigenetic and chromatin interaction analysis.
Aim 2a Identification of polymorphic BACh sites that potentially promote metastasis. I
identified 4T1-specific BACh sites based on BACh analysis mentioned in Aim 1. In parallel, I
compared the single nucleotide polymorphisms (SNPs) in five pairs high- and low-metastatic
mouse strains (BALB/cj (high) and SEA/GnJ (low); AKR/J (high) and RF/J (low); C57BL/10J
(high) and C57BR/J (low); C57BL/10J (high) and C58/J (low); CAST/Ei (high) and MOLF/Ei
(low)) to filter for the SNPs specifically located in low metastasis strains that potentially
suppress metastasis. To enrich for chromatin sites affecting metastasis progression, I identified
4T1-specific BACh sites that have filtered low metastasis associated SNPs residing in.
Hypothesis/Rationale: Based on human studies, it indicates that the majority of diseaseassociated polymorphisms are non-coding124 and therefore likely mediate their effects through
subtle changes in gene transcription125,126. Previously study showed the five low- metastasis
mouse strains were derived from a highly metastatic strain FVB/NJ inbred to other mouse strains.
We assumed the acquired low metastatic potential were due to the differed genetic background
of the parental mouse strains. Different mouse strain pairs that are close phylogenetically but
with high- and low- metastasis were used for SNP analysis. SNPs unique in low metastatic
strains are implied to associate with metastasis, therefore, the alteration of which in metastatic
cells is one probable reason to cause metastasis susceptibility. The polymorphic BACh sites
mapped out by BACh sites with those low-metastasis-associated SNPs inside in metastatic
mouse cell were identified to be metastasis associated via promoter or non-promoter regulation
on target genes.
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Aim 2b Identification of candidate metastasis susceptibility genes and pathways. I mapped
out the connectivity between potential regulatory elements and gene promoters using RNAPII
ChIA-PET. Combined with identified polymorphic BACh sites that associate with metastasis
susceptibility, I identified candidate metastasis susceptibility genes in each pair of mouse strains.
By intersecting the genes identified from the five pairs of mouse strains, I got a core set of
metastasis susceptibility gene candidates. To better understand the potential function of these
candidate genes, I performed pathway analysis to categorize the functions and build up the
network for metastasis development.
Hypothesis/Rationale: Genes associated with identified polymorphic BACh sites in Aim 2a
would be enriched for factors necessary for the conversion of dormant solitary tumor cells to a
proliferative metastatic lesion. Based on this hypothesis, the application of ChIA-PET can
improve the specificity to identify genes and pathways associated with metastasis. Previously,
putative candidate genes were identified by proximity to DHS and subsequent analysis indicated
that these candidates were enriched for factors and mechanisms associated with progression in
both mouse models and human breast cancer patients. Despite the success of these studies, two
major limitations were present that decreased the specificity of this analysis. First, whole genome
DHS data does not permit refinement or filtering of candidate genes for specific points along the
metastatic cascade, specifically at the most clinically relevant point of the dormant-toproliferative transition. Second, identification of candidate genes by proximity to DHS sites
introduces significant false positive and false negative data, since it is known that chromatin
structure can bring distant enhancers into contact with promoters by looping. By mapping the
chromatin interactions such as enhancer-promoter interactions, it is more specific and trustable to
identify the genes connected with polymorphic BACh sites.
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Aim 2c Validation of identified genes and pathways. To investigate the role of genes and
pathways within the identified candidates in Aim 2b, I selected glucocorticoid receptor signaling
for validation. I implanted 6DT1 cells into mice and treated them with dexamethasone to activate
glucocorticoid signaling. By comparing the local and metastatic tumor burden between
dexamethasone-treated and control mouse group, the influences of glucocorticoid signaling
pathway was evaluated.
Hypothesis/Rationale: As a set of genes and pathways were identified to be associated with
metastasis using genetic and epigenetic tools in Aim 2b, within which, some are novel that have
never been reported. It is meaningful to further validate their important roles by animal
experiment.
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1.4 Background and Significance
Recent 3D genome studies demonstrated genomic distance is not always consistent with
physical distance in vivo, linear arrangement of the genome cannot fully represent the
mechanism responsible for transcription regulation. Techniques that combine biochemistry with
high-throughput sequencing such as Hi-C and ChIA-PET have been used to map chromatin
loops that physically interact at long distances, and these interaction maps have been used to
infer the 3D structures of the genome. Comparative analysis of different cells showed that the
higher-order genome organization such as chromatin interactions could lead to cell-specific
transcription by shaping nuclear topology, and suggested enhancer-promoter interactions
significantly enriched for cell-specific functions.
Due to limitations in imaging resolution inherent to conventional microscopy, the spatial
organization of higher-order chromatin structure has historically been difficult or impossible to
directly observe. With the application of super-resolution microscopy, people started to see
functional genome structures inferred by sequencing data. For example, STORM combined with
DNA FISH has been used to image chromatin folding of TAD and different epigenetic states
inferred by Hi-C63,65. However, more detailed structures beyond TAD such as chromatin loop are
still elusive. As one of the most well-established super-resolution light microscopies that can
achieve the best resolution up to 20 nm axially, iPALM will provide the best chance to resolve
the most fundamental functional chromatin unit.
Breast cancer is the most common malignancy and the second leading cause of cancerrelated deaths among women (https://seer.cancer.gov/statfacts/html/breast.html). Although recent
evidence suggests that some improvement has also been seen over the years for patients with
metastatic disease127, disseminated tumors remain the proximal cause of the majority of breast
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cancer deaths. Improved understanding of the unique dependencies and vulnerabilities of
disseminated tumor cells and their resulting macroscopic lesions would therefore have the
potential to improve patient survival by exploitation of metastasis-specific targets and pathways
to eliminate life threatening metastasis.
Molecularly, metastasis results from ectopic gene expression that is affected by genetic
and epigenetic events. Therefore, comprehensive study is necessary by combining genetic and
epigenetic analysis based on genome-wide sequencing technologies.
A central aim in this study is to dig out the regulatory elements especially enhancers and
understand the mechanism of distinct genome organization that programs the cellular function
and biological processes. Studies in genome organization and gene regulation have provided new
insights into transcription regulatory mechanisms and disease development109,128,129. Via
chromatin looping enhancers can affect the expression of target genes located far away in linear
distance. It has been reported that disease-associated variation is especially enriched in enhancers
of disease-relevant cell types, and cancer cells generate enhancers at oncogenes and other genes
important in tumor pathogenesis. Hence, higher-order chromatin conformation could be a critical
determinant in breast cancer metastasis.
As a result of genetic screen in mouse models, SNPs that are found to be associated with
differential metastatic capacity can be utilized as “fingerprints” on the genome to indicate which
genes, regardless of previous knowledge or known functionality, play important roles in tumor
progression. These “fingerprints” can subsequently be used to retrospectively construct the
probable biology along the metastatic cascade on which genes or DNA elements act without
direct observation. Based on a genetic screen that demonstrated a significant role of inherited
SNPs in the progression of a transgene-induced model of mammary tumor metastasis130,131, a
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number of genes have been implicated in the predisposition of this mammary tumor model to
form pulmonary metastatic lesions115,132,133, several of which have also been potentially
implicated in human metastasis susceptibility133–137. Although these studies have implicated new
genes in tumor progression, each appears to contribute relatively small amounts of the
phenotypic variance, suggesting that metastasis susceptibility is a complex trait that is the
combined result of many different genes acting additively or interactively. In order to more
comprehensively and specifically interrogate the targets genome-widely, it is promising to utilize
sequencing tools that map the epigenomic features combined with SNPs to identify genes and
pathways that are associated with metastasis but missed in traditional genetic studies.
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1.5 Outline
This thesis consists two projects to study chromatin interaction in mammalian cells. Each
aim of the projects is described and discussed in the following chapters.
Chapter 2: Super-resolution imaging of a distinct chromatin loop in human
lymphoblastoid cells
Chapter 3: Investigation of enhancer regulation on metastasis by chromatin
interaction in mouse cells lines
Chapter 4: Identification of a core metastasis susceptibility network by integrating
genetic, epigenetic and chromatin interaction analysis.
The last chapter concludes the results and findings and discusses the limitations and
future directions.
Chapter 5: Conclusions, limitations and future directions
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Chapter 2: Super-resolution imaging of single
chromatin loop in human lymphoblastoid cells
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Chapter 2
2.1 Introduction
Chromatin organization is a fundamental mechanism for gene transcription regulation.
DNA is condensed in different levels in cell nucleus. The lower level 10 nm DNA fiber is folded
into higher-order chromatin structures that allows further compaction fitting into the nucleus
which tightly associate with transcription regulation and cellular function. The higher-order
genome structure is elusive for tens of years. Advanced technologies for in vivo analysis are
highly desired to decipher the higher-order genome structure. Recently, technologies combining
biochemistry and high-throughput sequencing such as Hi-C and ChIA-PET have been developed
to genome-widely characterize long-range interaction (usually from several kilobase to hundreds
kilobase) that is considered as the basis of higher-order chromatin organization in order to map
the whole genome structure. Chromatin interactions suggests a DNA looping and folding
conformation that distant chromatin loci can physically contact with each other. Based on
mapped chromatin interactions, complex structures with mega bases of DNA such as TAD
and CTCF-mediated chromatin contact domain (CCD) have been proposed and defined. More
importantly, these sequencing inferred structures were proved to be involved in transcription
regulation and disease development. Thus, they have critical biological importance. However,
the visualization of these hypothesized higher-order chromatin structures in situ remains difficult
mainly due to resolution limitation of conventional microscopy. Though electron microscopy had
been used to visualize the ultrastructures and 3D organization of chromatin directly138,139, it
lacked specificity with the restriction of labeling methods to be used in investigating
transcription associated chromatin structures. Fortunately, super-resolution light microscopy has
made it possible to achieve the goal. Recently, STORM has been used to image chromatin
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folding of TAD and different epigenetic states inferred by Hi-C63,65. With this success, there
comes a more intriguing challenge to visualize a distinct chromatin loop. In this study, we
applied super-resolution microscopy iPALM combined with FISH to visualize a specific
chromatin loop that very frequently occurred in human lymphoblastoid GM12878 cells inferred
by Hi-C and ChIA-PET chromatin contact data, which enabled us to resolve the very fine
chromatin looping structures within 33 kilobases of DNA.
The iPALM imaging was done in Janelia campus, Howard Hughes Medical Institute,
helped by Jesse Arron. The chromatin modeling and analysis were mostly done by Zofia Parteka
and Przemyslaw Szalaj in University of Warsaw.
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2.2 Materials and Methods
Cell culture
GM12878 cells were cultured in RPMI 1640 with 2mM L-glutamine and 15% fetal bovine serum
at 37 °C.
Nuclei isolation
Nuclei EZ Prep Nuclei Isolation Kit from Sigma was used to isolate nuclei from GM12878 cells.
Coverslip coating
Coverslips were incubated in 1M KOH for 20min, washed with water, coated with 0.01% polyL-lysine (Sigma) for 20min, rinsed with water, dried for 30min for later use.
DNA FISH
Isolated nuclei were added to attach to poly-L-lysine coated coverslips, fixed with 4% PFA for
10min at room temperature, washed with 1x phosphate-buffered saline (PBS), permeabilized
with ice-cold methanol for 10min, washed with 1 x PBS, dehydrated with 75%, 85% and 100%
ethanol for 2min each, dried at 60°C for 1h. FISH probes were mixed with hybridization buffer
and added to prepared nuclei, denatured at 80°C for 5min, incubated in a humid chamber at 37°C
for overnight. Nuclei were washed with 50% formamide/2 x SSC at room temperature for 10min,
followed by 2xSSC for 10min, 0.2 x SSC at 55°C for 10min and then large volume of 2 x SSC
till imaging.
iPALM imaging
Samples were imaged in standard STORM buffer by iPALM (Shtengel et al., 2009). Isolated
nuclei were adhered to 25mm round coverslips containing gold nanorod particles that act as
calibration standards and alignment/drift fiducial markers. These were prepared as described in
(https://www.sciencedirect.com/science/article/pii/B978012420138500015X).

Briefly,

coverslips

were
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washed for 3 hours at 80 degrees C in a 5:1:1 solution of H2O:H2O2:NH3OH, rinsed copiously,
and coated with poly-L-lysine. After further washing, gold nanorods (Nanopartz, Inc) were
adhered to poly-L-lysine coated coverslips, washed again, and coated with ca. 50nm SiO2 using
a Denton vacuum evaporator. Samples were mounted in dSTORM buffer140, containing tris
buffered saline, pH 8, 100mM mercapto ethanolamine, 0.5 mg/mL glucose oxidase, 40 ug/mL
catalase, and 10% (w/v) glucose (all from Sigma). An 18mm coverslip was adhered atop the
bottom coverslip, sealed, mounted in the iPALM, and imaged as described above.
Image pre-processing
iPALM images were reconstructed via localization of blinking fluorophores over 25,000 frames
across each of three Electron-multiplying charge-coupled device (EMCCD) cameras. Gold
nanoparticles act as fiducial markers that allow for (1) spatial registration of the three cameras
using a full affine transformation, and (2) calibration of the z-position response of the
system. After localization, images were filtered to only include localizations with <30nm
uncertainty in all three dimensions. The gold fiducial particles also allow for drift correction in
all three dimensions, and for correcting any sample tilt to within 30nm error. Final images were
rendered as image stacks, reflecting the fluorophore density and uncertainty of localization, or
exported as ASCII delimited text files for further analysis.
Spots identification
Connected component in graph theory is a set of nodes (subgraph) such that all of the nodes are
connected by vertices. In image processing we are looking at voxels with different brightness
levels. We defined a connected component as a part of the image in which all of the voxels form
an area with brightness level above given threshold. By changing the brightness cutoff level, we
can split an image into different sets of connected spots (Figure 2.4).
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Algorithms for connecting identified spots
To comprehensively model the peak joining possibility, we applied three different algorithms to
render the models. After that we apply spline Interpolation to smooth the models.
Nearest neighbor (NN) algorithm Nearest neighbor algorithm is solving shortest path problem.
Shortest path problem in graph theory is the problem of finding a path between two nodes such
that the distance between them is minimized. Algorithm is starting from given point, searching
the nearest point in surroundings, connecting them and again searching for the nearest neighbor
and this way connecting a whole set of points. After analyzing the genomic data, we found out
that examined loop is in between two subdomains. We assumed that flanking regions will be far
apart from each other with the loop in the middle. We run two NN simulations each starting from
one of two points that were furthest apart in space. Thus, this program will generate two possible
image models.
Traveling salesman problem solver (TSP) algorithm We used implementation of greedy
algorithm finding one of best solutions for this NP-hard problem. We treat our set of points as
graph nodes, and distances between them as vertices. At the beginning each vertex is a separate
path of length 1. In each step we are finding two closest disconnected paths, and we connect
them into one. This step is repeated until there is just one path left. Greedy TSP solver gives
highly non-optimal results therefore after connecting all paths into one we run optimization
algorithm. Optimization tries to rearrange points in the path to improve the solution. After
finding the shortest path we are simply deleting the longest connection between two points. This
way we get the shortest path between two points that are the furthest from each other.
Neighbor joining (NJ) algorithm Neighbor Joining is an agglomerative clustering method used
in bioinformatics for creation of phylogenetic trees. In each step the algorithm is searching for a
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pair of points that are the closest to each other and connecting them in one. This step is repeated
until there is no unconnected points left. We used this approach to connect sets of points from
iPALM images.
Spline Interpolation
This is a type of interpolation which uses splines, special polynomials, to construct new set of
data points. We used it to smooth structures after connecting spots from iPALM images.
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2.3 Results
Chromatin landscape of target region and visualization by DNA FISH
Hi-C and ChIA-PET data both showed chromatin loops at various genomic loci and
length scales. After we examined the whole genome, we selected the target genomic region in
chromosome 14, which contains a high frequency loop that is about 13kb long and mediated by
both CTCF and RNAPII in GM12878 cells (Figure 2.1B and Figure 2.2). It is located at the Tcell receptor alpha (TCRA) locus where V(D)J recombination takes place during T-lymphocyte
development and has been observed and studied in mouse T cells141–143. Specifically, a CTCFand cohesin-binding site is located between TCRA locus and the neighboring housekeeping gene
DAD1, functioning as an insulator, as the depletion of cohesin led to an increased transcription
of DAD1144. Interaction between TCRA enhancer and Dad1 was shown to occur both in mouse
T- and B-lymphocytes, although in the latter it was slightly weaker143,144. The conservation of
TCRA locus in mouse and human145 implies a similar chromatin conformation in human
lymphocytes with mouse. Expectedly, in our GM12878 ChIA-PET data, one anchor of the loop
overlapped with TCRA enhancer, the other anchor is situated in Dad1 gene body (Figure 2.1B),
which is similar to the observation in mouse T cells, suggesting the insulation function of our
target loop in human cells, adding biological meaning to the study on its detailed folding
conformation.
To keep the integrity of the loop in consideration of staining efficiency, we extended
10kb at both sides. Basically, we were investigating a 33kb chromatin region that contains an
interaction loop inside that is shown in both chromatin interaction heat map (Figure 2.1A) and
genome browser (Figure 2.1B). The surrounding epigenomic landscape of this region is shown in
(Figure 2.2). By genomic modeling, we reconstructed the conformation of the target based on
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sequencing data (Figure 2.1C). However, the chromatin structure inferred by population data
lacks specificity and accuracy of individual cells or alleles, which led us to interrogate it by
super-resolution imaging. Oligopaints probe46 for DNA FISH was designed to target on the
chromatin specifically by avoiding DNA repeats region, resulting a staining density of about 10
oligos/kb, allowing us to visualize the target chromatin as a dot by conventional microscope,
though lacking details of the structuring. The composition of each probe oligo was shown in
Figure 2.1D.

Fine structures of target chromatin revealed by 3D super-resolution iPALM
imaging
We applied iPALM58 to samples labeled with Atto647N, achieving the resolution at
single molecule level (Figure 2.1E). We acquired six good quality images of the target chromatin
(Figure 2.1E) for following analysis.
Briefly, samples were imaged at 30-50ms exposure, under 3kW/cm2 of 647nm laser
excitation and 100W/cm2 405nm laser activation for 25,000 frames to capture blinking Atto
647N molecules. Data was imported into the PeakSelector software package (Janelia Research
Campus), which registers each of the three camera images with respect to each other, calibrates
the intensity across each camera as a function of z-position, and localizes each blinking molecule
in 3D. Further, fiducial nanoparticles embedded in the coverslip allow for drift correction after
acquisition and localization to maximize image resolution. By pre-processing, localizations were
filtered based on localization uncertainty in all three dimensions and data were rendered as
3D .tif stacks or exported as vectorized datasets for further analysis.
Each image (Figure 2.1E) shows a one copy of the 33 kb chromatin target. The wellseparated red spots represent single fluorescent molecules bound along the chromatin. From the
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images, we can tell the spots are not randomly distributed but conformed in some order to build
featured structure.
A

chr14:22.7Mb – 24.05Mb

D

23.018Mb – 23.048Mb

E

B
CTCF

RNAPII

C

Figure 2.1 Experimental design and acquired images
(A) Representation of the target chromatin loop by Hi-C heatmap. The upper heatmap
shows a larger view of the chromatin loop inside. The lower heatmap shows the exact
target region for visualization, within which, the blue and green dots indicate RNAPII
mediated and CTCF mediated chromatin loops, respectively, inferred by ChIA-PET.
(B) Browser view of CFCF and RNAPII mediated chromatin loop of the target region.
(C) Modeled chromatin structure using Hi-C and ChIA-PET data.
(D) Probe design for DNA FISH and schematics of iPALM imaging.
(E) Six acquired images for the distinct chromatin loop by iPALM.
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chr14:20,000,000-26,500,000

ChIA-PET
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RNAPII loop
RNAPII peak

Figure 2.2 Landscape of the chromatin loop
The left panels are the browser views of ChIA-PET data for the chromatin loop and its
surroundings. The middle panels are ChIA-PET heatmaps for the corresponding chromatin loop
and surrounding regions. The right panels are Hi-C heatmaps for the corresponding regions.
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Reconstruction of chromatin targets from iPALM images
We modeled the chromatin structure by extracting and connecting all the spots in the
images using different algorithms. All six images were analyzed to get confident single molecule
spots from pre-processed images (Figure 2.3A). Basically, we extracted significant signals,
measured brightness of images in relative luminosity units which range from 0 to 255.
Brightness threshold was chosen manually to cut off noises. We then started from the lowest
brightness level (threshold level) and increasing the value by ten in each step, until we reached
maximum brightness of the image (Figure 2.4). In this way we examined different sets of spots
of signals at each step, that allowed us to identify all spots desired. The number of spots varied
between different images, ranging from 42 to 110 (Table 2.1), which is much smaller than the
total number of probe oligos for each copy of chromatin target. A couple of reasons can cause
this under-stained effect: the chromatin cannot be ideally fully stained due to the FISH efficiency;
some signals can get lost during data processing. We then characterized each image by spot
count and volume, as well as the nearest distance between spots (Figure 2.3B, 2.3C, 2.5). The
average dot count of each image is 68, and volume is 0.005 µm3 (Table 2.1). The nearest
distance enriched in the spectrum of 0-60 nm. Intriguingly, each structure of the target looks
different from another, indicating the heterogeneity of the genome across cells, at this higherorder level.
As there is no obvious way to determine the orientation of the target chromatin loop from
the staining, we used three different algorithms to simulate and reconstruct the chromatin
conformation. Each set of points was connected using NN, NJ and TSP algorithms (Figure 2.3D,
E, F, G). The obtained structures were smoothed using cubic spline interpolation. Four simulated
structures were generated for each image. We then measured the linear length of these modeled
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structures (Table 2.2). Considering the probing density is in average of 10 fluorophore/kb, it is
about able to resolve up to the lower level “beads on string” structure with around 150 bp per
unit, even though the DNA is under-stained. As previously reported, the first level of DNA
compaction from base pair backbone to histone modified “beads on string” structure is about five
to ten-fold condensation in size8. Therefore, our target 33 kb chromatin is estimated to be around
2244 nm to 4488 nm by first level compaction. Compared with our modeled DNA length, most
of them are within the estimated range, only two of the images have shorter length, which may
suggest a truncated chromatin structure due to the limitation of imaging penetration depth.
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Figure 2.3 Image characterization and modeling
(A) Signal extraction from image 2. Each red spot indicates one fluorophore tagged with DNA
probe oligos.
(B) 3D volume of Image 2.
(C) Distance distribution of the nearest spots in Image 2.
(D) (E) (F) (G) Image modeling with different algorithms for Image 2.
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Figure 2.4 iPALM image processing algorithm
The upper panel is a schematic illustration to extract probe spots from preprecessed. The lower panel is a processing example of Image 2
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Figure 2.5 Characterization of volumes and distances between spots for each image
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Table 2.1 Characterization of images
Image 1

Image 2

Image 3

Image 4

Image 5

Image 6

50

80

42

73

51

110

3,906,301

6,077,427

2,753,653

4,716,177

1,993,389

11,434,228

Spot count
Volume (nm )
3

Table 2.2 Linear length of image models
Linear length of the models for images (nm)
Algorithm

Image 1

Image 2

Image 3

Image 4

Image 5

Image 6

NJ

2297.63

2569.35

3150.5

3481.72

1699.51

1897.23

2842.1

3218.16

1775.18

1967.29

4751.28

5346.97

NN1

2143.24

2320.08

2420.73

2651.38

1428.13

1562.75

2621.51

3092.21

1589.24

1743.19

3581.4

3829.22

NN2

1968.2

2119.16

2531.7

2730.49

1432.12

1606.68

2402.78

2592.97

1590.37

1742.47

3716.58

4013.24

TSP

1848.5

2038.64

2422.66

2596.36

1267.72

1383.92

2238.86

2404.38

1312.37

1417.93

3364.43

3623.48
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Correlation of physical coordinates with chromatin contact mapping data
To assess the concordance between imaging and sequencing data, we analyzed the Hi-C
data for the loop region. Based on the location of contact anchors we defined four contact
categories: loop (with both anchors contained within the loop region), flank (with both anchors
located in flank regions), loop-flank (with one anchor in loop region and the other in one of the
flanks) and inter-flank (with anchors located in flanks on both sides of the loop) (Figure 2.6A).
As expected, we noted that the interaction frequency of the contacts within loop or flank
as seen in Hi-C heatmap was significantly higher than for the loop-flank and inter-flank (Figure
2.6C, 7, 8, 9, 10, 11, 12). Considering this effect is to some extent due to higher frequency of
contacts between regions located close to each other, we removed the shortest contacts from the
analysis and observed very similar patterns.
We also analyzed the relation between physical distance as measured in imaging-based
structures between pairs of points and the frequency of contacts between the corresponding loci.
We assumed that chromatin loops are highly flexible and that they can take different
conformations across time and different cells. Thus, to identify the expected patterns and
variability we used molecular dynamics simulations to model a number of toy regions with
varying pattern of contacts. We modeled the loop region using a beads-on-a-string model with
340 equidistant points. A random walk structure was used as the initial configuration. The
simulation was run for 1000 steps, and the first 200 steps were discarded. Then we extracted
every twentieth frame and analyzed them both individually and collectively. As a result, most of
models has shorter distance in loop regions compared to the other three categories (Figure 2.7,
2.8, 2.9, 2.10, 2.11, 2.12). The imaging models generally exhibited similar patterns, but there
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was large variability between different methods and images. This suggests that the chromatin
loops are very flexible and dynamic.
For each model of the images we plotted the 3D distance between pairs of points against
the contact frequency from the corresponding Hi-C heatmap bins and genomic distance between
them (Figure 2.7, 2.8, 2.9, 2.10, 2.11, 2.12). In all the cases we observed that contacts
representing different types are relatively well-separated. In general, loop-flank and inter-flank
contacts are characterized by longer 3D distance and lower Hi-C frequency, whereas flank and
loop contacts tend to have smaller distances and higher contact frequency.
Looking back to all the models made from different algorithms, we found the NJ models
are the least matched with the hypothesis that the loop region has the shortest pair-wise physical
distances, while the NN models are the most matched, suggesting NN algorithm works the best
in this structure modeling.
A

B

C

Figure 2.6 Comparisons of image models with sequencing data
(A) Schematics of the target chromatin loop inferred by ChIA-PET data.
(B) The chromatin contact information characterized by 3D distance in different regions of the
chromatin loop indicated in (A) for Image 2 modeled by nearest neighbor 1.
(C) 3D scatter plot for chromatin contacts characterized by 3D distances in nearest neighbor1
modeled Image 2 and Hi-C frequency data.
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Figure 2.7 Comparisons of image models with sequencing data for Image 1
The top panels are image models from different algorithms. The middle panels are 3D distance plot
of the models. The bottom panels are the chromatin contact within the target region characterized
by 3D distance and Hi-C frequency.
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Figure 2.8 Comparisons of image models with sequencing data for Image 2
The top panels are image models from different algorithms. The middle panels are 3D distance
plot of the models. The bottom panels are the chromatin contact within the target region
characterized by 3D distance and Hi-C frequency.
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Figure 2.9 Comparisons of image models with sequencing data for Image 3
The top panels are image models from different algorithms. The middle panels are 3D distance
plot of the models. The bottom panels are the chromatin contact within the target region
characterized by 3D distance and Hi-C frequency.
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Figure 2.10 Comparisons of image models with sequencing data for Image 4
The top panels are image models from different algorithms. The middle panels are 3D distance
plot of the models. The bottom panels are the chromatin contact within the target region
characterized by 3D distance and Hi-C frequency.
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Figure 2.11 Comparisons of image models with sequencing data for Image 5
The top panels are image models from different algorithms. The middle panels are 3D distance
plot of the models. The bottom panels are the chromatin contact within the target region
characterized by 3D distance and Hi-C frequency.
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Figure 2.12 Comparisons of image models with sequencing data for Image 6
The top panels are image models from different algorithms. The middle panels are 3D distance
plot of the models. The bottom panels are the chromatin contact within the target region
characterized by 3D distance and Hi-C frequency.
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2.4 Discussion
This is the first time a candidate chromatin loop is investigated and visualized using
super-resolution microscope. Though we expected to see a major loop in the target chromatin
region inferred by ChIA-PET data, we observed more complex looping structures in each
individual image that differed from each other. There are a variety of possible reasons for the
observation. 1. The chromatin loop could be heterogeneous between cells and even alleles, or
dynamic other than static in different cell stages. The captured loop suggested by ChIA-PET data
just indicated one possible conformation that occurred most frequently at that region. It does not
mean other conformations could not happen as other types of conformations could be too rare to
be captured. Our imaging data is not inclusive enough due to the limitation of the sample size to
reflect the frequencies of each type of the looping incidences. 2. There are structures that cannot
be captured by molecular strategies. Both ChIA-PET and Hi-C are based on a hypothesis that the
chromatin interactions are mediated by protein factors. In other words, the chromatin that has no
protein binding cannot be captured and modeled, though we cannot deny there are ultra-complex
twisting and tangling for DNA packing in the nucleus.
This study allows a direct visualization of the chromatin looping in a specific region that
we clearly see the physical winding of DNA, though there are limitations hindering us from
interpreting the observations more comprehensively. For instances, we are not able to exactly
map the iPALM images to the corresponding genome coordinates; we have not got a chance to
image the non-looping regions inferred by genome sequencing data; a larger sample size would
be helpful bridging the gap of the comparisons between individual by imaging and population by
sequencing.
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The imaging data is more direct and straightforward for revealing chromatin
conformation than the sequencing data. Therefore, the observations or findings that are not in or
against our expectations from the sequencing data are not frustrating but even more suggestive to
the current understanding the chromatin looping.
As a pilot study, the experimental design could be further improved. As stated previously,
we were not able to distinguish the chromatin loop region and extended tails of the loop by
single color DNA FISH staining visualized by iPALM. In the future, dual color can be used to
stain the loop and tails separately, increasing the accuracy of the conformation corresponding to
the coordinates, decreasing the difficulties in the following modeling. To inclusively capture the
possible chromatin structures and estimate the distribution of the occurrence frequencies, a larger
sample size is needed. Furthermore, negative controls could be used for comparison, such as a
non-looping region in the same cell line or the same target region with a non-looping structure in
another cell line inferred by sequencing data. Besides the 13 kb chromatin loop at Chr14, it is
interesting to investigate other chromatin loops at different length scales in different
chromosomes. The fundamental principle of chromatin looping should be pursued.
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Chapter 3: Investigation of enhancer regulation on
metastasis by chromatin interaction in mouse cells
lines

54

Dissertation

Jacqueline Jufen Zhu

Chapter 3
3.1 Introduction
Metastasis is often found in breast cancer, which is the major cause to mortality.
However, the mechanism underlying is not clear. Studying the genome organization of cancer
cells can reveal higher order regulatory mechanism of tumorigenesis and metastasis and in order
to suggest clinical cure. Identification of these critical targets, however, has been challenging due
to the complex nature of the metastatic process. In breast cancer, patients can survive for years,
even decades, before the manifestation of metastatic disease146. During the years between the
diagnosis of the primary tumor and metastatic relapse, occult tumor cells have remained
undetected until some currently undefined and unobserved event results in their conversion to a
proliferative secondary tumor. Since millions of cells can be shed by the primary tumor per
day147 and dissemination can commence early in tumor evolution148,149, current hypotheses
suggest that the colonization step - the conversion from quiescent to actively growing tumor cells
- is likely the rate-limiting step in the metastatic cascade. However, as indicated above, the
quiescent-to-proliferative switch can occur anytime over a period of years to decades. This,
coupled with the estimate that less than 1 in 10,000 tumor cells is likely to make the
conversion150, makes direct visualization of the mechanisms and pathways involved very
challenging, even within model organisms.
Results from genomic studies indicate genome organization within the nucleus is
nonrandom, which suggests important functions in gene expression151,152. Higher-order genome
structure such as chromosome territory reorganization and gene repositioning were found to be
associated with human diseases and cancers17,96,153,154. More recently, studies showed genome
architecture mediate interactions between regulatory elements such as enhancers and gene
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promoters to allow delicate gene regulation31,106,109,155. However, since genomic distance is not
always consistent with physical distance in vivo, linear arrangement of the genome cannot fully
represent the mechanism responsible for transcription regulation. Techniques that combine
biochemistry with high-throughput sequencing such as Hi-C and ChIA-PET have been used to
genome-widely map long-range chromatin interactions. Bound by transcription factor complexes,
enhancers can be brought proximal to promoters to enhance gene transcription. Disruption of
these 3D structures can lead to enhancer malfunction resulting in inappropriate gene expression,
potentially leading to diseases and cancers73,86. It has been reported that disease-associated
variation is especially enriched in enhancers of disease-relevant cell types, and cancer cells
generate enhancers at oncogenes and other genes important in tumor pathogenesis109,156. Hence,
higher-order chromatin conformation could be a critical driver in breast cancer metastasis.
CRISPR-based technology validated the importance of one set of enhancer-promoter
interactions on target gene expression. Moreover, the analysis has been broadened to include
five genetically related but metastatically divergent strain pairs which allows the identification of
a core set of common metastasis susceptibility genes and molecular pathways. The results of
these studies implicated inherited variation in metabolic pathways as important common
mediators of metastatic progression. Furthermore, pre-existing therapeutics are implicated as
either potential pro- or anti-metastatic agents that might be used or avoided to reduce subsequent
metastatic burden. These studies therefore provide novel insights into a potential core set of
processes associated with breast cancer progression that might be exploited to reduce the burden
and mortality of breast cancer metastatic disease, as well as important insights into the epigenetic
regulation of metastatic progression.
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3.2 Materials and Methods
Cell Lines
4T1, 4T07 and 67NR30 were obtained from the laboratory of Lalage Wakefield (NCI) and
confirmed to be of BALB/c mouse origin by microsatellite genotyping. All cell lines were
mycoplasma-free.
Benzonase accessible chromatin (BACh) sequencing analysis
Cells were expanded in DMEM with 10% FBS and P/S at 37°C to obtain 8–10 x107
cells/condition/each experiment. BACh analysis was performed as previously described with
minor modifications157. Briefly, cells were collected by centrifugation, washed twice in ice cold
cellular wash buffer (20 mM TrisHCl pH 7.5, 137 mM NaCl, 1 mM EDTA , 10 mM sodium
butyrate, 10 mM sodium orthovanadate, 2 mM sodium fluoride, protease inhibitor cocktail
(Roche)) and resuspended in (40 million cells/ml) hypertonic lysis buffer (20 mM TrisHCl pH
7.5, 2 mM EDTA, 1 mM EGTA, 0.5% glycerol, 20 mM sodium butyrate, 2 mM sodium
orthovanadate, 4 mM sodium fluoride, protease inhibitor cocktail (Roche)). Cells were
distributed in 500µl aliquots in 1.5 ml tubes and followed by the addition of 500µl of nuclease
digestion buffer (40 mM TrisHCl pH 8.0, 6 mM MgCl2, 0.3% NP-40, 1% Glycerol) containing a
3-fold dilution (from 0.125 units/ml to 6U units/ml) of Benzonase (Calbiochem/EMD). This was
mixed gently and incubated for three minutes at 37°C. Reactions were terminated by the addition
of EDTA (10 mM final) and SDS (0.75% final). Proteinase K was added to a final concentration
of 0.5 mg/ml and incubated overnight at 45°C. DNA fragments of 100-500 bp from a chromatin
digestion were purified over sucrose gradients158 and precipitated in 0.1 volume NaAc and 0.7
volume isopropanol.
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Sequencing and data analysis of Benzonase-treated samples
DNA was sequenced using either Illumina HiSeq2000 (TrueSeq V3 chemistry) or NextSeq500
(TrueSeq High output V2 chemistry) sequencers at the Advanced Technology Research Facility
(ATRF), National Cancer Institute (NCI-Frederick, MD, USA).

The sequence reads were

generated as either 50-mer or 75-mer (trimmed to 50-mer by trimmomatic software before
alignment), and tags are then aligned to the UCSC mm9 reference genome assembly using Eland
or Bowtie2. All the samples had good quality with over 94% of the bases having Q30 or above
with 25~50 million raw reads per sample. Regions of enriched tags termed hotspots have been
called using DNase2Hotspots algorithm159 (http://sourceforge.net/projects/dnase2hotspots) with
FDR of 0% with minor updates. Tag density values were normalized to 10 million reads. For
comparison of BACh profiles across multiple cell lines, percent reference peak coverage (PRC)
measure was proposed and employed to ensure compatible levels of digestion by Benzonase in
multiple cell lines. To calibrate PRC, commonly represented hotspot sites were identified as
reference peaks based on mouse (mm9) DNaseq data from ENCODE. ENCODE narrowPeak
definition files (DNaseI Hypersensitivity by Digital DNaseI from ENCODE/University of
Washington) for a total of 133 samples were downloaded from the UCSC golden path web site:
http://hgdownload.cse.ucsc.edu/goldenPath/mm9/encodeDCC/wgEncodeUwDnase/. A total of
8,587 peaks were found to be present in all 133 samples. By assuming that the most commonly
accessible sites may also be present in our optimally digested samples, PRC was obtained as a
fraction of reference peaks presented in each sample to evaluate the level of digestion by
Benzonase. Two biological replicates with acceptable PRC were selected and pooled for each
cell line. When samples showed bimodality in their tag density distribution due to elevated noise,
we dropped hotspots that belonged to a group with low tag density and low PRC by applying
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threshold to maximum hotspot tag density values. Each hotspot was classified in relation to
genomic features, promoter, exon, intron, distal upstream and downstream classes, based on the
annotation

information

on

refGene.txt

downloaded

from

http://hgdownload.cse.ucsc.edu/goldenpath/mm9/database/. The classification of each BACh was
used to generate lineage plots for different BACh categories. Comparison of the relative position
of the retained versus lost BACh were shown by plotting empirical cumulative distribution
(ECDF) of the absolute distance to nearest transcription start site (TSS) from the mid-point of a
hotspot from two groups of BACh: BACh lost, (67NR, 4T07, 4T1) : (+, -, -) or (+, +, -), and
BACh retained, (67NR, 4T07, 4T1) : (+, +, +), as malignancy increases. The two distributions
were compared by two sample Kolmogorov-Smirnov test (K-S test)159.
Long Read ChIA-PET and data processing
Long read ChIA-PET was performed using Tn5 transposase to tag DNA for long tag sequencing
by Illumina Nextseq. ChIA-PET data was processed by a customized ChIA-PET data processing
pipeline54. Detailed protocol can be found in the paper “Long-read ChIA-PET for base-pair
resolution mapping of haplotype-specific chromatin interactions”160.
RNA-seq data analysis
DESeq2 was used to analyze the RNA-seq data for 4T1, 4T07 and 67NR cells to identify
differentially expressed genes. The cut-off used was 3-fold change of normalized gene
expression (baseMean), Padj < 0.01. By pair-wise comparison, over-expressed genes were
identified for each cell line compared to the other two cell lines.
Cell line specific enhancer identification
Based on identified over-expressed gene in 4T1, 4T07 and 67NR and RNAPII-mediated
chromatin interactions, genomic loci (promoter region excluded) that distantly interact with the
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gene promoters that have RNAPII binding peaks were filtered out as candidate enhancers. By
comparative analysis and subtractive strategy, the enhancers that specifically occurs in each cell
line but not overlap with any other regulatory elements interacting with promoters in the other
cell lines were further identified as cell line specific enhancers.
Fosb knockdown
DsiRNA for Fosb was designed and produced by IDT with sequence1:
rArCrArArUrCrUrArUrArUrCrGrUrUrGrArGrArArUrUrCTG and sequence2:
rCrArGrArArUrUrCrUrCrArArCrGrArUrArUrArGrArUrUrGrUrArA. Cells were transfected
using Lipofectamine RNAiMAX and then incubated for 72h for harvest (ThermoFisher
Scientific).
CldnE knockout experiment
Cas9 transgene was first introduced by infecting cells with lentivirus derived from plasmid
lentiCas9-Blast (gift from Feng Zhang; Addgene plasmid # 52962), followed by Blasticidin
selection, creating the 4T1_Cas9 cell lines. Then two plasmids expressing guides targeting
upstream (guide sequence: GAGTGAGTTCTCAGACAGCCA) and downstream (guide
sequence: GGTGTCTGTCCTTTACAGCA) of the CldnE were co-transfected with three knockin/knock-out plasmids each carrying an EF1a promoter driven antibiotic resistance gene casette
(Hygro, Puro, Neo) flanked by 1kb homology arms upstream and downstream of the CldnE
deletion region, into the Cas9-expressing 4T1_Cas9 cells. To select for multiple allelic
knockouts, cells were selected simultaneously with hygromycin, puromycin, and geneticin.
Single clone knockout was isolated by flow cytometry and genotyped by PCR and Sanger
sequencing. Primers for genotyping can be found in Table 3.1.
Table 3.1 Primers for genotyping
Name
Sequence
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CGGAACTTCAGTTGACTGCCTC
ctgtgttctggcggcaaacc
CGGAACTTCAGTTGACTGCCTC
CTATTGCAGGCTCAGGGCTAATC

qRT-PCR
Gene expression of CldnE knockouts was measured by qRT-PCR. Primers are attached in Table
3.2.
Western blot
Three CldnE knockout strains and 4T1_Cas9 as control were used in this assay. The experiment
was done following the general protocol from BIO-RAD. The gel image was analyzed using FIJI
to quantify the protein expression by measuring the raw intensity of the protein bands.
Wound healing and cell migration assay
Three CldnE knockout strains and 4T1_Cas9 as control were used in this assay. Culture dish
with silicone insert were purchased from Ibidi (Cat. # 80206). The same number of cells for each
strain was seeded in the inserts and after 24 hours culture a monolayer of cells and a defined 500
um cell free gap was formed. Images of the gap were captured every two hours till eight hours
with 10x objective of a widefield microscope (Leica DMi8). Size of the gaps at each time point
was measured using FIJI. The cell migration speed was calculated with a linear trend.
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Table 3.2 Primers for qRT-PCR
Name
Sequence
Actb F
CTCTGGCTCCTAGCACCATGAAGA
Actb R
GTAAAACGCAGCTCAGTAACAGTCCG
Cldn3 F
ACCAACTGCGTACAAGACGAG
Cldn3 R
CAGAGCCGCCAACAGGAAA
Cldn4 F
GTCCTGGGAATCTCCTTGGC
Cldn4 R
TCTGTGCCGTGACGATGTTG
Abhd11 F
ACTCCCAAGCCCGAAAAC
Abhd11 R
CGTATCCAAGTTCAGTCTCCAG
Fosb F
AGGCAGAGCTGGAGTCGGAGAT
Fosb R
GCCGAGGACTTGAACTTCACTCG
Cdh1 F
CACCTGGAGAGAGGCCATGT
Cdh1 R
TGGGAAACATGAGCAGCTCT
Wnt7a F
TGAAGAGGACCCAGTGACAGG
Wnt7a R
GGCGTACTGGTGTGTGTTGT
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3.3 Results
Identification of metastasis-associated genes and their regulatory elements and
factors in 4T1 cell line series
The tumors from these three cell lines - 67NR, 4T07 and 4T1 - span the malignant
spectrum when inoculated into the mammary fat pad of BALB/c mice, with 67NR remaining
localized, 4T07 disseminating to and remaining as single cells in the lung, and 4T1 forming
macroscopic pulmonary metastatic lesions. In order to examine the transcription associated with
metastasis, we performed RNA-seq with 4T1 cell series and identified 743, 620 and 968 upregulated genes in 4T1, 4T07 and 67NR, respectively, by comparative analysis (Figure 3.1A).
4T1 up-regulated genes were specifically enriched in tight junction and lipid biosynthesis (Figure
3.1B). Though tight junction usually is thought as a key component of maintaining cell adhesion
and tissue integrity to suppress metastasis of invasive tumor cells161,162, in 4T1 cell model, the
activated or enhanced expression of tight junction genes including Cdh1, Cldn3 and Cldn4 might
function to facilitate the cell colonization instead of building a barrier for secondary tumor
formation. In addition, many other 4T1 up-regulated genes identified here such as Wnt7a, Il1a
and Hoxa cluster have also been reported previously to be related to cancer metastasis163–167.
To answer the question how these metastasis-associated genes were regulated in the
perspective of higher-order genome organization, we analyzed the RNAPII ChIA-PET data to
characterize chromatin interactions with both anchors located at BACh to identify cell line
specific enhancers that were interacting with these genes. Specifically, 261 cell specific
enhancers were identified to connect with 175 colonization-associated genes and 567 cell
specific enhancers were interacting with 265 colonization suppressing-associated genes in 4T1
and 67NR, respectively. By analyzing this subset of enhancers and their targeting gene
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promoters, we found differential enrichment of protein-binding motifs at gene promoter and
enhancer region for both classes of genes (Figure 3.1C, Figure 3.2B). Enhancer region were
enriched for Fos:Jun (AP-1) family protein binding, while gene promoter region were mainly
enriched for Sp1 family protein. AP-1 family is known as important protein factors that are
crucial for human breast cancer metastasis168–170, but the regulation via enhancers hasn’t been
stated yet. Therefore, our study suggested its bidirectional role in regulating metastasis, that is, it
could either promote or attenuate metastasis progression in different cell lines.
To validate Fos:Jun family protein functions in regulating colonization-associated genes
in 4T1 cells, we performed RNAi to knock down a 4T1 up-regulated gene Fosb. The gene
expression of candidate targets that have Fos:Jun binding motif at their enhancer region (Figure
3.2A) were examined by qRT-PCR in Fosb knockdown cells where Fosb was down-regulated
about three fold (Figure 3.1D). Cldn3 and Cdh1 expression were observed to significantly
decrease, while Cldn4 and Wnt7a remained at the same expression level (Figure 3.1D) that might
be due to the binding of other Fos:Jun family proteins instead of Fosb. This result added
evidences to prove that Fos:Jun family protein regulate colonization-associated genes by binding
at enhancer sites.
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Figure 3.1 Characterization of cell up-regulated genes and associated enhancers in 4T1, 4T07
and 67NR
(A) Heap map shows the differentially expressed genes in 4T1, 4T07 and 67NR cells. By
comparing gene expression between cell lines using DESeq2, the conditions of defining gene
upregulation are log (fold change) > 1.5, FDR < 0.01. Red color indicates upregulation. Blue color
indicates downregulation.
(B) The enriched functions by gene ontology analysis of cell line up-regulated genes are shown
with FRD (left side) and fold enrichment (right side).
(C) Motif analysis was done with 276 identified BACh sites located within enhancer region as well
as their interacting promoters of 175 in 4T1 cells. The enhancers are enriched for Fos:Jun protein
family binding, while the promoters are enriched for SP1 family binding. Specifically, 59 enhancer
sites are found to have Fos:Jun binding motif and 60 sites have SP1 binding motif.
(D) Gene expression level was measured in Fosb knock-down cells. Metastasis-associated genes
Cldn3 and Cdh1 were significantly down-regulated in Fosb knock-down cells by RNAi.
2
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Figure 3.2 Binding motif analysis
(A) Examples of BACh sites located within enhancers that interact with metastasis-associated genes
and have Fos:Jun binding motif. Red color indicate Fos:Jun binding motif sequence.
(B) Motif analysis was done with 591 identified BACh sites located within enhancer region as well
as their interacting promoters of 265 in 67NR cells. The enhancers are enriched for Fos:Jun protein
family binding, while the promoters are enriched for SP1 family binding. Specifically, 143 BACh
sites are found to have Fos:Jun binding motif and 69 sites have SP1 binding motif.
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Gain or loss of functions of metastasis-associated genes by enhancer regulation
Enhancer interaction not only implicated important roles of certain transcription factors,
but also suggested an accurate regulatory mechanism of metastasis-associated genes. Some of
the identified genes were connected with more than one enhancer (Figure 3.3A, 3.4A, Table 3.3
and Table 3.4), building up a delicate and complex regulation system, which further implied their
importance in metastasis. For instance, Wnt7a was observed to be involved in a variety of
cancers171–173. In 4T1 cells, Wnt7a was found to promote breast tumor invasion and metastasis
via potentiating TGFb receptor signaling163. Comparatively, our study revealed Wnt7a promoter
was connecting to three potential enhancers located 20kb to 130kb away, either within gene body
or at non-coding region (Figure 3.3B). Another example comes in 67NR cells. A chemokine
gene Ccl7 that is broadly studied and reported to be associated with cancer progression174,175 was
highly expressed in 67NR cells, while had no expression in 4T1 cells. Within a 200 kb region,
Ccl7 promoter was interacting with eight enhancers that were only present in 67NR cells (Figure
3.4B). The gain or loss of enhancers would be one of the reasons for gain or loss of function of
metastasis associated genes.
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Figure 3.3 Characterization of 4T1-specific enhancers
(A) Enhancer distribution per gene in 4T1 cells was characterized. 261 identified enhancers are
connecting with 175 up-regulated genes. Most of the genes are interacting with one enhancer, but
the others interact with multiple enhancers.
(B) The example shows a gene interacting with multiple enhancers. 4T1-upregulated gene Wnt7a
is observed to interact with three enhancers. Green line indicates Wnt7a gene promoter site. Red
lines indicate enhancer sites.
(C) Gene distribution per enhancer in 4T1 cells is characterized. Most of the enhancers are
connecting with only one 4T1-upregulated gene, but 12 of them are interacting with two identified
genes and the other one is interacting with four genes.
(D) The example shows an enhancer interacting with multiple genes. An enhancer is interacting
with Cldn3, Cldn4 and Abdh11 directly. Cldn3 and Cldn4 are only expressed in 4T1 cells
compared to 4T07 and 67NR. Though Abhd11 is not that significantly up-regulated in 4T1,
decreased expression can be observed in 4T07 and 67NR. Green line indicates gene promoter sites.
Red line indicates the enhancer.
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Figure 3.4 Characterization of 67NR-specific enhancers
(A) Enhancer distribution per gene in 67NR cells is characterized. 567 identified enhancers are
connecting with 265 up-regulated genes. Most of the genes are interacting with one enhancer, but
the others interact with multiple enhancers.
(B) The example shows a gene interacting with multiple enhancers. 67NR-upregulated gene Ccl7 is
interacting with eight enhancers. Green line indicates Ccl7 gene promoter site. Red lines indicate
enhancer sites.
(C) Gene distribution per enhancer in 67NR cells is characterized. Most of the enhancers are
connecting with only one 67NR-upregulated gene, but 29 of them are interacting with two
identified genes.
(D) The example shows an enhancer interacting with multiple genes. An enhancer is interacting
with Mdm2 and Rab1b directly. Mdm2 and Rab1b are significantly up-regulated in 67NR cells
compared to 4T1 and 4T07. Green line indicates gene promoter sites. Red line indicates the
enhancer.
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Table 3.3 Multiple enhancer regulation on metastasis-associated genes in 4T1 cells
Gene Symbol
Enhancer Count Gene Symbol
Enhancer Count
Hes1
6
Fbln2
2
Cdh1
4
Gm14023
2
Endod1
4
Gm14207
2
Krt8
4
Gm15051
2
5430407P10Rik 3
Has2
2
Bdh1
3
Has2as
2
Cd24a
3
Hs3st1
2
Cgnl1
3
Inhba
2
Cldn4
3
Itga2
2
Cnnm4
3
K230010J24Rik 2
Epcam
3
Krt80
2
Filip1l
3
Lamc2
2
Gm16046
3
Lrp10
2
Pdgfb
3
Myo1d
2
Rbm47
Ripk4

3
3

Nuak2
Phldb2

2
2

Sorbs2
Tmprss11e

3
3

Plekha2
Pmepa1

2
2

Unc5b
Wnt10a

3
3

Rin3
Rnpep

2
2

Wnt7a
2010204K13Rik
5830416P10Rik
Bhlhe40
Cldn3
Ctgf
Dll4
Dnaja4

3
2
2
2
2
2
2
2

Sdc1
Sema3f
Susd1
Tmem51
Tnfaip3
Tuba4a
Ubtd2
Vegfc

2
2
2
2
2
2
2
2

Dock5
Epha1

2
2

Wwc2

2
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Table 3.4 Multiple enhancer regulation on metastasis-associated genes in 67NR cells
Enhancer
Enhancer
Gene Symbol
Gene Symbol
Gene Symbol
Count
Count
Plk2
16
Adm
3
Dnhd1
Ereg
10
Adrb2
3
Dysfip1
Gdnf
10
Amacr
3
Eml1
Jun
8
Ankrd57
3
Fam71f1
B430305J03Rik 8
Apcdd1
3
Fhl4
Ccl7
8
Aqp5
3
Foxd1
Pde2a
8
Atf1
3
Gm12981
2810474O19Rik 7
Csf1
3
Gm15608
Fgfr1
6
Dclk1
3
Gm17249
Gas1
6
Dhx29
3
Gm17443
2900052L18Rik 5
Fgf2
3
Gm2115
Bahcc1
5
Glipr1
3
Gpc4
Cdkn2a
5
Gm12824
3
Gpx8
Mex3b
5
Gm16508
3
Gypc
Sparc
5
Gm9949
3
Irx1
Xdh
5
Hrh1
3
Irx5
1700023H06Rik 4
Itga7
3
Kcnh1
A830082K12Rik 4
Kcnj2
3
Kitl
Abcb1b
4
Msx2
3
Layn
B230206L02Rik 4
Nt5dc3
3
Marcks
Cadm1
4
Osbpl5
3
Mrgprf
Cav1
4
Pak1
3
Naip2
Ccdc109b
4
Pcdh7
3
Nrg1
Chst1
4
Pik3r5
3
Pdpn
Dcun1d3
4
Pmp22
3
Plcl1
Dnajb4
4
Ppap2a
3
Prss42
Ecm1
4
Rap1b
3
Ptgs1

Enhancer
Count
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

Gm11216
Gm12056
Gm9958
Id2

4
4
4
4

Rrm2b
S100a7a
Sbno2
Tbx3

3
3
3
3

Qrfp
Rab30
Rnf11
Rusc2

2
2
2
2

Lrrk2
Lyrm1
Ndst3

4
4
4

Thbd
Tmem74
Tspan17

3
3
3

Sema5a
Sesn2
Siglecg

2
2
2

Otud1
Prrx1

4
4

Zbtb20
1700012B09Rik

3
2

Snora2b
Snord123

2
2
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1700086P04Rik
2610037D02Rik
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9230114K14Rik
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4
4
3
3
3
3
3
3

9130023H24Rik
A430110N23Rik
A930001C03Rik
Aen
Ankrd55
Ap3b2
Atp13a4
Cpne2

2
2
2
2
2
2
2
2

Tgfb1i1
Tgfbr3
Tigd5
Tmem45a
Tusc1
Usp14
Vgll3
Zfpm2

2
2
2
2
2
2
2
2
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Multitasking-enhancers regulate more than one metastasis-associated gene
In addition to multiple enhancers being associated with a single gene, enhancers were
identified that interacted and potentially regulated multiple metastasis-associated genes. In this
study, we identified 13 and 29 multitasking-enhancers in 4T1 and 67NR cells, respectively
(Figure 3.3C, Figure 3.4C, Table 3.5, Table 3.6). Multitasking-enhancers are expected to be
more powerful than single-tasking enhancers, since they have the potential to regulate
metastasis-associated genes and pathways in a more efficient manner. Figure 3.3D and Figure
3.4D show examples of multitasking enhancers in 4T1 and 67NR.
Claudin are the most important component of cell tight junction, which stand out in 4T1
cells by gene ontology analysis. They are known to associate to breast tumor malignancy176–181.
By comparison, Cldn3 and Cldn4 were highly expressed in 4T1 cells, while no expression was
detected in 4T07 and 67NR cells. A multitasking-enhancer was identified and named as CldnE
interacting with Cldn3 and Cldn4 genes, as well as an abhydrolase gene Abhd11 in 4T1 cells
(Figure 3.3D), suggesting its important role in metastasis regulation. To interrogate whether the
onco-enhancer is functional other than only structural, we implemented CRISPR/Cas9 to knock
out the target enhancer CldnE (chr5: 135441137-135443563). Before knocking out, we prepared
a 4T1_Cas9 cell line by lentivirus infection on 4T1 to constitutively express Cas9 protein. Then
we transfected 4T1_Cas9 cells to replace CldnE with drug-resistant genes by homology-directed
repair (HDR) (Figure 3.5A) for following knockouts selection. Considering the aneuploidy of
4T1 cells, we designed three different drug-resistant gene donors for HDR to guarantee at least
three copies of CldnE were simultaneously knocked out in a single 4T1_Cas9 cell by drug
selection. When we got a puromycin-, geneticin- and hygromycin-resistant knockout cell
population, flow cytometry was applied to sort them into single cells. We then randomly picked
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ten single cell colonies that were genotyped (Figure 3.6A, 3.6B) to have interrupted CldnE for
transcription quantification. Expectedly, by qRT-PCR, we observed a dramatic decrease of the
target gene expression (Figure 3.5B), validated the regulatory function of multitasking-enhancer
CldnE. We also performed Western blot to investigate the protein expression of Cldn3 and Cldn4
in three single cell CldnE knockout clones. Compared with the control cells, one of clones had
Cldn3 and Cldn4 protein dramatically down-regulated; the other two clones also showed
decreased expression though not that significant except P1C10 expressed about the same level of
Cldn4 with wildtype cells (Figure 3.6C). The statistics showed us Cldn3 protein was
significantly down-regulated to 0.6-fold of the control and Cldn4 was about 0.8 fold.
Furthermore, to examine if metastasis potential has been changed within these CldnE knockouts,
we performed wound healing assay, which showed the knockouts migrated significantly slower
than the control (Figure 3.5C, 3.5D), without observing a significant difference in cell
proliferation. In addition, mouse implantation was conducted by injecting CldnE knockouts or
control cells into nude mice. 30 incidences in lung (ten incidences for each cell line) were
observed to count for micrometastasis in two CldnE knockouts and one control cell line. The
micrometastasis is defined as metastatic seeds that have not yet development into visible
macrometastatic tumors but can be observed as speckles. Though no significant difference was
seen in macrometastatic pulmonary tumors (Figure 3.6D), micrometastasis was observed by
H&E staining significantly less frequently occurred (P-value = 0.02235) in CldnE knockouts
(Figure 3.5E). Therefore, we proved the pivotal role of Cldn3, Cldn4 genes and provided insights
into the potential therapeutics in cancer metastasis by targeting on enhancers.
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Figure 3.5 Functional validation of CldnE knockout by CRISPR
(A) The schematic shows CRISPR knock-out strategy. HDR are introduced to both sides of the
CldnE enhancer region. Three different antibiotics are knocked in when enhancers are knocked out
to increase the probability of enhancer knock-out at more than three alleles in single cell by further
antibiotics selection.
(B) qPCR is done to measure the target gene expression in control and ten single cell clone CldnE
knockouts. Cldn3, Cldn4 and Abhd11 are all significantly down-regulated in the knockouts. “*”
indicates P-value is less than 0.05 by t-test.
(C-D) Wound healing and cell migration assay. (C) Three single cell clone knockouts are selected
for wound healing and cell migration assay. Images were taken every two hours till eight hours
from the start. Here only 0-, 4- and 8-hour images are shown. Compared with control cells,
knockout cells are observed to migrate slower. (D) Migration speed is calculated based on the
measurement from the images. The control cells migrate at the speed of 116 μm/h, while knockouts
migrate at 62 μm/h. (E) Micrometastasis was counted in knockouts and control cells. Ten
incidences were observed for each cell lines. One incidence is one speckle observed in H&E
staining.
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Figure 3.6 Characterization of CldnE knockouts
(A) Gel picture shows CldnE wildtype and knock-out DNA fragments. The upper bands indicate
CldnE knockout genotype, which only shows up in the ten single cell clone knockouts but not in
control. The lower bands indicate CldnE wildtype genotype, which shows up in all the samples,
suggesting CldnE knock-out is not complete in the ten knockout cells.
(B) CldnE knockout genotype is sequenced. The sequence spans the EF1α promoter in the
targeting constructs to CldnE flanking region.
(C) The upper panel shows Western Blot result of Cldn3, Cldn4 and Gapdh in 4T1_Cas cells and
CldnE knockouts. The raw intensities of protein bands are measured using FIJI. Normalized by
Gapdh, Cldn3 and Cldn4 expressed in CldnE knockouts are compared with 4T1_Cas9. The
number underlying each band indicates the relative intensity of the band. The lower panel shows
the statistics of Cldn3 and Cldn4 protein level in CldnE knockouts.
(D) Primary, pulmonary metastatic tumor weight were measured in mouse implanted with
knockouts and controls. Normalized metastasis was calculated.

Table 3.5 Multi-tasking enhancers in 4T1 cells
Enhancer Coordinate
Gene Count
chr6:52023797-52028187
chr12:103004008-103005806

4
2

chr12:82719533-82721279
chr14:56342201-56344158

2
2

chr15:37049761-37051327
chr15:56552071-56554508

2
2

chr15:56672483-56673912
chr2:119136894-119138322

2
2

chr2:119139504-119140698
chr2:129236520-129240516
chr5:135430733-135444258
chr7:141450421-141454102
chr9:110582929-110584694

2
2
2
2
2
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Table 3.6 Multi-tasking enhancers in 67NR cells
Enhancer Coordinate
Gene Count
chr10:117303670-117305698
2
chr11:120113330-120115578
2
chr11:120165218-120167654
2
chr11:120167679-120170193
2
chr11:120176495-120179043
2
chr11:120213812-120216549
2
chr13:113650957-113653080
2
chr13:113991211-113994366
2
chr14:31716840-31718849
2
chr15:32251683-32253349
2
chr15:32444308-32445350
2
chr18:62209005-62211249
2
chr18:62321109-62323590
2
chr18:62362078-62364487
2
chr3:32407170-32410547
chr4:132000670-132003197

2
2

chr4:140982579-140984296
chr4:95527757-95529526

2
2

chr5:18422249-18423650
chr7:127030594-127032230

2
2

chr7:127104239-127105575
chr7:127240748-127242263
chr7:135487713-135489437
chr7:87274020-87276902
chr7:99863142-99865504
chr7:99980076-99982095
chr8:33211357-33212580
chr8:33310000-33311769

2
2
2
2
2
2
2
2

chr9:110683374-110685628

2
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3.4 Discussion
Though the epithelial to mesenchymal transition is usually considered as a marker of
metastasis, 4T1 mouse cell model showed a totally different mechanism. Metastatic 4T1 cell has
more epithelial features while non-metastatic 67NR is more likely to be in mesenchymal stage.
This phenomenon demonstrates the mesenchymal features are not always the markers or drivers
for metastasis. Though theoretically, the mesenchymal cells are more likely to metastasize, other
steps of metastasis can also be crucial such as colonization. 4T1 cells have tighter cell junction,
likely to circulate in colony and colonize to the secondary tumor site more easily than 67NR cells.
It is interesting that Fos:Jun was found to be involved in enhancer regulation in both
metastatic and non-metastatic cells. It is hard to know if the same Fos:Jun proteins function
oppositely in different cells or different Fos:Jun proteins take care of different metastatic
potentials.
Enhancer has been well studied to regulate genes and associate with diseases. However,
multitasking enhancer regulating cancer development is rarely studied. These powerful
enhancers could be the potential targets for therapeutics.
By analyzing chromatin interactions between DNA elements and gene promoters, we
should be able to identify other regulatory elements such as silencers and insulators besides
enhancers. Enhancers are well-studied and found to play important roles in activating or
enhancing gene transcription. While, we know relatively little about silencers, which functions in
the opposite to enhancers, silencing or weakening gene transcription. Insulators work to insulate
certain connections between gene and regulatory elements or between different chromatin
domains. Genome architectural proteins such CTCF and cohesin are often seen to bind with
insulators to cooperate insulation. For examples, the boundaries of TADs or insulated
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neighborhood domains function as insulators to regulate transcription. Therefore, CTCF ChIAPET could be used to examine insulator distribution. Similar to enhancer analysis, comparative
analysis of chromatin interactions in 4T1 cell line series could identify metastasis-associated
silencers and insulators or chromatin domains that participate in metastasis progression.
I mainly focused on intra-chromosomal chromatin interactions in this thesis. However,
inter-chromosomal interactions also exist and play important roles in genome organization and
cellular function. To more comprehensively understand the associations of chromatin
organization and gene transcription, inter-chromosomal interactions between promoters and
regulatory elements should not be ignored. Preliminarily, I have observed interactions between
metastasis-associated genes and multi-tasking enhancers inter-chromosomally by DNA FISH
(Figure 3.7A, Table 3.7). In metastatic 4T1 cells, the co-localization frequency of a distinct Myc
enhancer (named MycE) and other metastasis associated genes in different chromosomes is
significantly higher than in non-metastatic 67NR cells and normal NIH3T3 cells (Table 3.7) as
well as controls in 4T1, whereas the differences of co-localization frequency between target pairs
and controls in 67NR is not as significant as in 4T1 (Table 3.7), indicating an involvement of
MycE in regulating metastasis associated genes in trans in metastatic cells. Furthermore, we have
validated the function of MycE by CRISPR knockout. In MycE knockouts, metastasis associated
genes such as Cldn3, Cldn4, Cdh1 and Wnt7a were significantly down-regulated as well as Myc
(Figure 3.7B). Considering Myc may have influences on other genes, we overexpressed Myc in
MycE knockouts (Figure 3.7C) and measured the expression of candidate MycE regulating genes
again. The results showed Cdh1 expression was not rescued in Myc overexpressed MycE
knockouts (Figure 3.7C) validating MycE is promoting metastasis-associated gene expression at
least on Cdh1.
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Figure 3.7 Chromatin interaction between MycE and metastasis-associated genes in trans
(A) The co-localization of MycE and Cldn3,4.
(B) Gene expression in MycE knockouts. By qRT-PCR measurement of transcription in 13 MycE
knockouts, Cldn3, Abhd11, Cdh1 and Wnt7a were significantly down-regulated as well as Myc.
(C) Gene expression in Myc overexpressed MycE knockouts. In Myc overexpressed
4T1_Cas9_koMycE_Myc cells, Cdh1 expression were not rescued compared with control
4T1_Cas9_knoMycE_Ctr and its parental 4T1_Cas9 cells by qRT-PCR.
Table 3.7 Co-localization frequency of MycE and metastasis associated genes
MycE- MycECtr- MycECtr- MycEMycEMycECtr- MycECell
Cldn
CldnCtr
Cldn
CldnCtr Wnt7a
Wnt7a
Cdh1

MycECtrCdh1

4T1

24.4%

5.3%

10.3%

13.6%

23.2%

9.0%

22.5%

6.4%

67NR

12.0%

15.4%

6.9%

10.7%

18.3%

13.5%

19.6%

10.7%

NIH3T3 6.8%

7.8%

81

Dissertation

Jacqueline Jufen Zhu

Chapter 4: Identification of a core metastasis
susceptibility network by integrating genetic,
epigenetic and chromatin interaction analysis
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Chapter 4
4.1 Introduction
Unbiased screens, such as meiotic genetic susceptibility analysis, provides one method to
begin to implicate pathways and genes in difficult-to-observe phenomenon. Genetic screens can
be performed to identify inherited polymorphisms that affect the final outcome of a phenotype,
such as overt metastatic disease, without the need for pre-existing hypotheses about where in the
metastatic cascade a particular factor acts. SNPs that are found to be associated with differential
metastatic capacity in tumor progression can be used to retrospectively construct the probable
biology along the metastatic cascade on which a gene or genes act without direct observation,
much like clues used to reconstruct events at a crime scene.
Based on this premise, we developed a genetic screen that demonstrated a significant role
of inherited polymorphisms in the progression of a transgene-induced model of mammary tumor
metastasis130,131. We utilized a strategy that integrated a subtractive SNP screen between closelyrelated inbred strains with differing metastatic potentials to identify polymorphisms that were
enriched for metastasis suppressing functions126. To further filter the SNPs, we subsequently
focused only on SNPs that mapped within DHS of a publicly available mouse mammary tumor
cell line. This strategy was based on human studies that indicate that the majority of diseaseassociated polymorphisms are non-coding124 and therefore likely mediate their effects through
subtle changes in gene transcription125,126. Putative candidate genes were identified by proximity
to polymorphic DHS sites and subsequent analysis indicated that these candidates were enriched
for factors and mechanisms associated with progression in both mouse models and human breast
cancer patients126.
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Despite the success of these studies, there are limitations such as the ignorance of distal
regulatory elements that connect with certain metastasis associated genes. Therefore, we refine
the integrated strategy by specifically focusing on candidate genes enriched for the quiescent-toproliferative conversion by using BACh sites identified in three cell lines of the 4T1 cell line
series, which represent different stages along the metastatic cascade182. Furthermore, BACh-togene assignment was refined by the use of RNAPII ChIA-PET analysis, which specifically maps
chromatin interactions mediated by RNA polymerase II, to provide physical evidence of
polymorphic BACh interaction with gene promoters.
The work in this chapter was mostly done by Kent Hunter group in National Cancer
Institute. I have contributed in doing the chromatin interaction related analysis.
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4.2 Materials and Methods
Computing environment
All computations at NCI were performed on the NIH helix/biowulf system, documentation of
which is available at https://helix.nih.gov. We used R computing environment, Perl scripts,
Bedtools, and UCSC liftOver for most of the analyses.
Identification of polymorphic BACh sites
The workflow consisted of the following: 1) the BACh data were filtered for the regions
overlapping with polymorphic sites. Since the BACh data were generated in Genome Build
mm9, we used UCSC mm9 snp128 data to restrict the BACh sites. 2) Vcf were filtered to retain
the SNPs that overlap with the BACh present in the 4T1, 4T07 and 67NR cell lines. 3) SNPs
were removed in the BACh that are present in the mouse FVB/NJ strain.
Effect of Pioglitazone treatment on pulmonary metastases
1x105 cells/mouse of the mammary tumor cell line 6DT1 were orthotopically implanted into the
fourth mammary fat pad of female FVB/NJ mice (6-8 weeks old). Ten days post-implantation,
all of the animals were combined into a single cage then randomly assigned to treatment or
control group by alternating assignment to new cages. Pioglitazone (100µM) or vehicle (DMSO,
0.17%) was added to drinking water 10 days post tumor implantation and available to mice ad
libitum. Drinking water with Pioglitazone or DMSO was refreshed every week. Tumor growth
was monitored and animals were euthanized 28 days post implantation. Tumors and lungs were
evaluated for weight and surface metastases respectively. The experiment was performed twice
and the results were analyzed using the Mann-Whitney test and the results of the independent
experiments combined using the weighted Z-method183. All procedures were performed as
approved by the NCI-Bethesda Animal Care and Use Committee.
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Effect of Dexamethasone treatment on pulmonary metastases
1x105 cells/mouse of the mammary tumor cell line 6DT1 were orthotopically implanted into the
fourth mammary fat pad of female FVB/NJ mice (6-8 weeks old). 10 days post-implantation all
of the animals were combined into a single cage, then randomly assigned to treatment or control
group by alternating assignment to new cages.

Dexamethasone was administered by

intraperitoneal injection at 5 mg/kg of body weight in PBS daily for 21 days. At the end of the
treatment period, animals were euthanized and tumor weights and pulmonary metastatic lesions
enumerated. The experiment was performed twice and the results of the Mann-Whitney test
were combined the weighted Z-method183. All procedures were performed as approved by the
NCI-Bethesda Animal Care and Use Committee.
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4.3 Results
Correlation of the number of BACh sites in the 4T1 cell line series with metastatic
potential
To identify BACh that are associated with the colonization of metastatic secondary sites,
analysis of three of the cell lines from the mouse 4T1 mammary tumor cell line panel was
performed. BACh analysis was performed to identify metastatic 4T1 cell specific sites (Figure
4.1A). Based on the hypothesis, genes associated with these BACh would be enriched for factors
necessary for the conversion of dormant solitary tumor cells to a proliferative multicellular
metastatic lesion.
Biological duplicate BACh analysis was performed on each cell line. Analysis comparing
the replicate samples indicated a high degree of reproducibility (R>= 0.90) (Figure 4.2A). The
data for the replicate experiments were pooled and the BACh patterns for the three cell lines
examined. Comparison of the BACh between the different cell lines revealed a total of 3580
4T1-specific BACh sites that might be associated with metastasis susceptibility genes (Figure
4.1B). In addition, an unexpected significant inverse correlation was observed between the
malignancy of the cell lines and the number of BACh, with a total of 43,112 BACh observed in
the benign 67NR cell line, 38,106 in 4T07, and 27,156 in the fully metastatic 4T1 cell line. To
confirm that the loss of BACh was not due to a technical artifact, the data were analyzed for a set
of reference BACh in each cell line (Figure 4.2A, 4.2B and Figure 4.1C). The analysis indicated
that approximately 90% of the reference BACh were successfully captured in each cell line,
indicating that the decrease in BACh across the cell lines was not likely due to the relative
efficiency of BACh capture in each line (Figure 4.1C).
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The relative position of the BACh to known TSS was then examined to determine if
specific classes of BACh were progressively lost during increased metastatic progression. The
number of BACh sites associated with promoter elements - defined as regions 2.5 kb upstream of
the transcriptional start site to 2.5 kb downstream - was approximately equivalent across all three
cell lines. This suggested that approximately the same number of genes were transcriptionally
active across the cell lines; subsequent analysis of RNA-seq data was consistent with this
interpretation. In addition, RNA content per cell was not found to be significantly different
among the three cell lines, indicating that a general decrease in transcription had not occurred. In
contrast to the promoter BACh, BACh within introns, overlapping exons, or residing either
upstream or downstream of TSS all showed progressive loss across the cell lines. Analysis of the
relative position of the retained versus lost BACh revealed that BACh farther away from
transcriptional start sites were preferentially lost as malignancy increased (Figure 4.2D).
Stratification by genomic position further revealed that preferential loss of distant BACh was
restricted to BACh outside of gene bodies, suggesting a progressive closure of potential distant
enhancer elements as the mammary tumor cell lines gained metastatic potential.
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Figure 4.1 Characterization of chromatin accessibility by BAChs
(A) Schematic of the different classes of Benzonase accessible chromatin sites (BAChs) for the
4T1 cell line series. Left is a depiction of the tumor phenotypes in three cell lines, with the
localized 67NR tumor at the top, the disseminating but not metastatic 4T07 in the middle, and
the highly metastatic 4T1 tumor at the bottom. BACh sites are represented by the green peaks.
The 4T1-specific BAChs are indicated by the red box.
(B) Venn diagram of the BACh site overlap in the 67NR, 4T07 and 4T1 cell lines.
(C) Lineage plots of BAChs in the 4T1 cell line series. Dark blue represents sites present in
67NR that persist or reoccur in 4T07 and 4T1. Brown indicates BACh sites that appear in 4T07
that persist in 4T1. Light blue indicates BACh sites that appear specifically in 4T1. Numbers in
the lineage plots indicate the number of BACh sites in each category for the three cell lines. The
annotation for each genomic and sub-genomic analysis is indicated above the individual lineage
plots.
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Figure 4.2 Evaluation and characterization of BACh sites
(A) BACh site replication, overlap and genomic annotation data for the duplicate samples for
67NR, 4T07 and 4T1 cell line. The left figure in each row shows the correlation of the BACh for
each duplicate sample. The Venn diagram in the center displays the overlap of BACh identified in
the cell line replicates. The histogram on the right shows the overlap of DHS with respect to gene
features.
(B) Lineage plots of BACh in the 4T1 cell line series. Dark blue represents sites present in 67NR
that persist or reoccur in 4T07 and 4T1. Brown indicates BACh sites that appear in 4T07 that
persist in 4T1. Light blue indicates BACh sites that appear specifically in 4T1. Numbers in the
lineage plots indicate the number of BACh sites in each category for the three cell lines. The
annotation for each genomic and sub-genomic analysis is indicated above the individual lineage
plots.
(C) BACh sites evaluation by PRC. A total of 8,587 peaks were found to be present in all 133
samples. PRC was obtained to evaluate the level of digestion by Benzonase. Our pooled samples
with PRC of 90% or greater indicate that all 8,587 sites were present in the sample. Two
biological replicates with acceptable PRC were selected and pooled for each cell line, and each
pooled data set showed over 90% PRC.
(D) Plot of the relative position of persistent or lost Benzonase accessible chromatin sites
(BAChs) to transcriptional start sites (TSS) across the 4T1 cell line series. BACh sites that are
maintained across the cell lines are represented by the blue line, while lost BAChs are represented
by the red line.
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Identification of polymorphic BACh sites and associated genes
Next, we sought to filter the 3580 4T1-specific BACh for those likely to be associated
with inherited susceptibility to developing metastatic disease. Previously, we demonstrated that a
subtractive strategy comparing phylogenetically closely-related mouse strains with different
metastatic capacities was an effective method of identifying potential metastasis-associated
genes. Here, by focusing on the 3580 4T1-specific BACh sites and multiple paired high- and
low-metastatic mouse strains, we further refined this strategy to identify a common set of
metastasis-associated candidates enriched for genes potentially involved in the dormant-toproliferative colonization switch. Five different mouse strain pairs were selected for this analysis
based on close phylogenetic relationships and positions on either end of the inherited metastatic
efficiency spectrum (Figure 4.3A, 4.3B).
To identify polymorphic BACh that might influence the transcription of metastasisassociated genes, SNPs present in the low metastatic strain were extracted from those present in
its closely-related highly metastatic relative to enrich for variants that suppress metastatic disease
(Figure 4.3C). To specifically enrich for those polymorphisms affecting transcription of potential
colonization-suppressing genes, the variants were filtered for those that fall within the 3580 4T1specific BACh. This resulted in 1053-7396 SNPs present in 339-2254 BACh sites for the five
strain pair comparisons (Table 4.1).
It is known that enhancer elements can be at a considerable distance from their target
genes and chromosomal looping can result in enhancer-promoter contacts that reach over
intervening genes. Polymorphic BACh-gene assignments based only on proximity therefore
likely results in a significant degree of both false-positive and false-negative associations. To
improve the accuracy of candidate gene discovery we therefore performed RNAPII ChIA-PET in
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the 4T1 cell line identify RNAPII mediated chromosomal contacts between polymorphic BACh
and active or poised promoters. Polymorphic BACh were used to identify initial intrachromosomal loops connecting the BACh with distant positions. The initial ChIA-PET end pairs
were then used to seed a walking strategy to identify gene promoters in close proximity to
polymorphic BACh via intra-chromosomal looping (Figure 4.3C). A total of 358,508 paired end
tags were identified by the RNAPII ChIA-PET analysis in 4T1 cells, of which 85,853
represented intra-chromosomal looping events. Interestingly, a similar reduction of the number
of RNAPII binding peaks was observed across the 4T1 cell line series as seen for the BACh sites,
with 29971 RNAPII binding peaks in 4T1, 41809 in 4T07 and 40513 in 67NR cells (Figure
4.4A). Similar trend of BACh sites and RNAPII binding peaks, indicates a positive correlation of
chromatin accessibility and transcriptional activity.
Applying the polymorphic BACh/ChIA-PET walking strategy to each of the five mouse
strain pairs resulted in the identification of 587-2123 genes (Table 4.1) that were in contact with
polymorphic BACh and whose expression might therefore be influenced by the inherited
polymorphisms. The resulting gene lists for each of the mouse strain pair subtractions were then
compared to identify a core set of candidate metastasis susceptibility genes. 338 genes were
found to be in common in the five separate analyses, potentially representing a common set of
functions necessary for metastatic progression in the PyMT mouse mammary tumor model
(Table 4.2; Figure 4.3D). To determine whether a significant fraction of these genes might
represent identity by descent due to the shared inheritance of common inbred mouse strains, the
overlap of polymorphic BACh and SNPs was also examined. Only nine polymorphic BACh
were common to the five different strain combinations (Figure 4.4B), and no SNPs were shared
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(Figure 4.4C), indicating that different inherited polymorphisms and haplotypes were tagging the
same set of genes through long range intra-chromosomal architecture.
To determine whether the core metastasis susceptibility candidate genes might share
common transcriptional regulatory elements, promoter motif analysis was performed using the
GREAT tool. Five motifs were observed to be over-represented in all five strain comparisons,
including the previously characterized Sp1 and ELK1 transcription factor binding sites (Table
4.3), which is consistent of the promoter binding motif analysis in Chapter 3 (Figure 3.1C). The
three additional sequence motifs have not previously been associated with transcription factor
binding. These motifs may therefore represent binding sites for novel transcription factors with
important roles in metastatic breast cancer progression (Table 4.3).
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Figure 4.3 Gene identification by ChIA-PET and polymorphic BACh analysis
(A) Phylogenetic relation of the pairs of high- (blue) and low- (red) metastatic mouse strains used in
the analysis are shown.
(B) Histogram of relative metastatic capacity in the selected strain pairs across the full inbred strain
survey. Y-axis represents the average number of metastases observed per animal. X-axis indicates
the identity of the inbred strain bred to the PyMT model. The number of animals analyzed in each
breeding is indicated below the x-axis. Blue bars indicate strains that displayed no significant
difference in metastatic capacity compared to the original FVB background of the PyMT mammary
tumor model. Red bars indicated strains that showed statistically significant reduction of metastatic
disease, calculated by pairwise Mann-Whitney t tests.
(C) Schematic of the analytic genome-wide strategy used to identify potential metastasis
susceptibility genes. Single nucleotide polymorphisms that distinguish the phylogenetically highly
related high and low strains were filtered for those that fall within 4T1-specific BACh sites and are
therefore most likely associated with alterations in transcriptional activity. The polymorphic BACh
sites were then used to nucleate a walking strategy with the RNAPII ChIA-PET looping data to
identify gene promoters that were in contact with the BACh site. (D) Venn diagram showing 338
genes in common were identified as having their transcriptional start sites tagged by the polymorphic
BACh-ChIA-PET walking strategy in all five strain pair combinations.
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Figure 4.4 Venn diagrams of BACh sites, RNAPII binding peak and SNPs
(A) Similar amount of shared and unique sites was identified in BACh sites and RNAPII binding
peaks.
(B) Analysis of the overlap of polymorphic DHS in the five comparisons revealed only 9
polymorphic BACh in common.
(C) SNP analysis in the polymorphic BACh revealed that no variants were common for the five
strain pair comparisons.
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Table 4.1 Results of Integrated DHS, SNP and ChIA-PET screening strategy
Mouse Strain
Pairs

RF subtracted
by AKR

C58 subtracted
by C57BL10

C57BR subtracted
by C57BL10

SEA subtracted
by BALB

SNPs in DHS
Polymorphic DHS
Tagged TSS

1053
339
587

1234
373
616

1236
399
690

2571
802
1155

MOLF
subtracted by
CAST
7396
2254
2123

Table 4.2 Putative Common Core Metastasis Susceptibility Genes
Gene Symbol
1110008P14Rik

Csnk2b

Gstp1

Il1a

Pacsin3

Src

1700092M07Rik

Ctsw

Gstp2

Il1b

Pak6

Srrm2

1810009A15Rik

Cyb561a3

Gtf2h4

Incenp

Pcnxl3

Ssfa2

1810055G02Rik

D030056L22Rik

Guca1b

Ints5

Pfdn4

Ssna1

4933433C11Rik

D17H6S53E

H2-D1

Itprip

Phf19

Ssrp1

Abhd16a

D17H6S56E-5

H2-K1

Jmjd8

Pigyl

Sssca1

Abt1

D730039F16Rik

H2-Q4

Kat5

Pitpnm1

Stx5a

Adrm1

Dagla

H2-T23

Kremen2

Pkmyt1

Surf4

Agpat2

Ddah2

H2-T24

Lama5

Pmepa1

Surf6

Ahnak

Ddb2

Hat1

Lnpep

Pnpla7

Suv420h1

AI462493

Ddr1

Hcfc1r1

Lpin2

Polr2g

Synj2

AI837181

Ddx39b

Hist1h1a

Lrrc26

Ppp1r18

Taf6l

Alkbh3

Decr2

Hist1h1b

Lrrn4cl

Ppp2r5b

Tceb2

Anapc2

Dhx16

Hist1h1c

Lrsam1

Procr

Tgif1

Anxa1

Dnmt3b

Hist1h1d

Lsm2

Prrc2a

Thbs4

Ap5b1

Doc2g

Hist1h1e

Ltbp3

Psat1

Thoc6

Apom

Dpf2

Hist1h1t

Ly6g5c

Psmd5

Tle4

Arfgap2

Drap1

Hist1h2ab

Ly6g6c

Psors1c2

Tmem138

Arhgap40

Dus3l

Hist1h2ac

Ly6g6f

Rab31

Tmem151a

Arhgef28

Dusp5

Hist1h2ad

Lyst

Rab3il1

Tmem179b

Arpc5l

Ecsit

Hist1h2ae

Lzts2

Rabepk

Tmem203

Arrdc1

Edem2

Hist1h2af

Manbal

Rad9a

Tmem210

Asb13

Eef1g

Hist1h2ai

Map3k11

Rbl1

Tmem223

Atat1

Efemp2

Hist1h2ak

Mdc1

Rbm39

Tmem258

Atp5e

Efna5

Hist1h2an

Med22

Rela

Tmem8

Atp6v1g2

Ehbp1l1

Hist1h2bb

Minpp1

Rgs19

Tnfrsf12a

Atrn

Ehmt1

Hist1h2bc

Mroh8

Rin1

Tor4a

Atrnl1

Ehmt2

Hist1h2be

Mrpl11

Ring1

Tprn

AU023871

Eif1ad

Hist1h2bf

Mrpl28

Rnaseh2c

Traf1

Axin1

Elof1

Hist1h2bg

Mrpl41

Rnf208

Tsga10ip

B3gat3

Eml3

Hist1h2bh

Mrps18b

Rnf24

Ttc9c

B3gnt1

Fads3

Hist1h2bm

Msh5

Rom1

Tubb4b

B4galt7

Fam166a

Hist1h2bp

Mta2

Romo1

Tubb5
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Bag6

Fam69b

Hist1h2br

Mtl5

Rpl35

Tut1

Banf1

Fam89b

Hist1h3a

Mus81

Rpl7a

Ubxn1

Blcap

Fbxw2

Hist1h3b

Mybpc3

Rpl9-ps6

Uqcrb

Brd3

Fen1

Hist1h3c

Myl12a

Rpn2

Urm1

Brms1

Fibp

Hist1h3d

Myl12b

Rps21

Vars

Cables2

Flot1

Hist1h3e

Ncs1

Rrbp1

Vars2

Camsap1

Flywch2

Hist1h3f

Ndor1

Sart1

Vwa7

Ccdc147

Fnbp4

Hist1h3g

Ndufv1

Scd2

Wdr43

Ccdc64b

Fosl1

Hist1h3h

Nelfb

Scgb1a1

Wdr5

Ccdc85b

Frmd8

Hist1h3i

Nelfe

Scyl1

Wdr74

Ccdc94

Fth1

Hist1h4a

Neu1

Serinc5

Wdr85

Cd248

Gal3st3

Hist1h4b

Neurl1b

Serpinb6a

Xrn2

Cdk2ap2

Ganab

Hist1h4c

Nfe2l2

Sf3b2

Yif1a

Cds2

Ggta1

Hist1h4d

Nfkbil1

Sgms1

Zbtb3

Cep110

Ghrh

Hist1h4f

Nfs1

Skiv2l

Zc3h6

Cep250

Gm10197

Hist1h4h

Nrarp

Slc25a12

Zc3h8

Cfl1

Gm10762

Hist1h4j

Nrm

Slc25a45

Zfp184

Chka

Gm10767

Hist1h4k

Nudt8

Slc29a2

Zfp213

Ckap2l

Gm10800

Hnrnpa3

Nxf1

Slc34a3

Zfp653

Cldn6

Gm16181

Hnrnpul2

Ola1

Slc3a2

Zmynd19

Cldn9

Gm711

Hsd17b12

Olfr1424

Smc3

Clic1

Gm757

Hspa1b

Osbpl2

Smndc1

Cnn1

Golga1

Hspa5

Ovol1

Snx32

Commd7

Gpank1

Ier3

P2rx3

Snx9

Table 4.3 Significantly enriched promoter motifs in core metastasis susceptibility candidate genes
Transcription Factor

Motif

(no known TF)

KRCTCNNNNMANAGC

Hyper FDR Q-Val
RF
C58
subtracted
subtracted
from AKR
from C57BL10
1.90E-28
7.68E-28

Sp1

GGGCGGR

1.61E-06

0.028

2.72E-15

6.40E-13

2.53E-22

TTTNNANAGCYR

4.64E-15

1.45E-15

6.36E-12

2.63E-11

8.76E-06

SCGGAAGY

0.027

0.032

0.0065

9.88E-08

1.02E-05

GATTGGY

0.00064

0.0099

0.0035

0.0034

2.68E-05

(no known TF)
ELK1, member of
ETS oncogene
family
(no known TF)

C57BR
subtracted
from C57BL10
2.03E-26

SEA
subtracted
from BALB
4.58E-20

MOLF
subtracted
from CAST
2.93E-15
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Disease and function analysis of metastasis susceptibility candidates
Literature searches were performed for the 338 candidate metastasis susceptibility genes
to investigate previous associations with metastatic disease. Two genes (Brms1, Mta2) among
the 338 have previously been extensively studied for their role in metastatic disease184,185.
Moreover, an additional 30 genes have previously been implicated in phenotypes associated with
metastatic disease, including invasion, migration, epithelial-to-mesenchymal transition (EMT)
and prognosis, consistent with the screen enriching for metastasis-associated factors.
To better understand the potential molecular and cellular functions represented from the
338 genes, Ingenuity Pathway Analysis was performed. Disease and Function analysis revealed
two major categories associated with the putative core gene set (Figure 4.5A; Table 4.4). The
first category was formation of nucleosomes and DNA replication. The second association was
with diabetes mellitus. shRNA-mediated knockdown of peroxisome proliferator-activated
receptor (PPAR), a target molecule for diabetes, was therefore performed and found to increase
metastatic capacity in a tumor-autonomous manner (Figure 4.5B, 4.5C). Treatment of animals
with Pioglitizone, a PPAR antagonist, reduced metastatic capacity of the tumors (Figure 4.5D,
4.5E). Together, these studies provide support that the metabolic diabetes mellitus axis may be
part of the common breast cancer metastatic machinery that might be exploitable for clinical
intervention of metastatic colonization.
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Figure 4.5 Disease and functional pathway analysis
(A) Disease and Function results of the Ingenuity Pathway Analysis of the core 338 genes.
(B-E) Effects of Pparg (panels B and C) or Pioglitizone (panels D and E) on pulmonary
metastases (B and D) and the primary tumor growth (C and E) of the 6DT1 allograft
mammary tumor cells. The figure represents the combined results of two independent
experiments for each experimental condition. P-values were calculated for each experiment by
two-tailed Mann Whitney test, using Graph Pad Prism v 7, and subsequently combined using
the weighted Z-method.
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Table 4.4 IPA Disease and Function Analysis of Core Metastasis Susceptibility Genes
Categories
Cancer, Organismal Injury and Abnormalities, Reproductive
System Disease
Cancer, Organismal Injury and Abnormalities

Diseases or Functions
Annotation

p-Value

breast or ovarian cancer

8.77E-03

breast or ovarian carcinoma

2.04E-02

Gene Expression

transcription of RNA

1.39E-02

Immunological Disease
Cancer, Endocrine System Disorders, Organismal Injury and
Abnormalities, Reproductive System Disease
Connective Tissue Disorders, Inflammatory Disease, Skeletal
and Muscular Disorders
Metabolic Disease
Connective Tissue Disorders, Inflammatory Disease,
Inflammatory Response, Skeletal and Muscular Disorders
Endocrine System Disorders, Gastrointestinal Disease,
Metabolic Disease
Inflammatory Disease
Endocrine System Disorders, Gastrointestinal Disease,
Immunological Disease, Metabolic Disease
Connective Tissue Disorders, Immunological Disease,
Inflammatory Disease, Inflammatory Response, Skeletal and
Muscular Disorders
Protein Synthesis

systemic autoimmune syndrome

3.06E-06

ovarian cancer

2.09E-02

Rheumatic Disease

5.97E-05

glucose metabolism disorder

3.05E-03

inflammation of joint

1.90E-05

diabetes mellitus

1.01E-03

chronic inflammatory disorder

4.33E-04

insulin-dependent diabetes mellitus

3.73E-11

rheumatoid arthritis

2.07E-05

polymerization of protein

8.84E-06

Antimicrobial Response, Inflammatory Response

antimicrobial response

1.36E-04

Cell Death and Survival
Cellular Assembly and Organization, DNA Replication,
Recombination, and Repair
Cellular Development, Cellular Growth and Proliferation,
Connective Tissue Development and Function
Cancer

cell death of connective tissue cells

2.86E-02

formation of nucleosomes

3.03E-18

proliferation of fibroblast cell lines

3.00E-03

cell transformation

6.82E-03

Post-Translational Modification, Protein Synthesis
Cancer, Organismal Injury and Abnormalities, Reproductive
System Disease
Embryonic Development
Organismal Injury and Abnormalities, Reproductive System
Disease
Antimicrobial Response, Inflammatory Response

heterotetramerization of protein

2.73E-17

cervical tumor

1.47E-02

size of embryo

6.42E-03

noninflammatory cervical disorder

2.86E-02

antiviral response

1.30E-03

Lipid Metabolism, Small Molecule Biochemistry

metabolism of phospholipid

9.33E-04

Lipid Metabolism, Small Molecule Biochemistry

synthesis of phospholipid

2.16E-04

Cell Death and Survival

cell death of melanoma cell lines

5.25E-03

Organismal Injury and Abnormalities, Tissue Morphology

size of lesion

6.22E-03

Cell Cycle

G2 phase

9.55E-03

DNA Replication, Recombination, and Repair

repair of DNA

1.74E-02

Cancer, Organismal Injury and Abnormalities

invasive cancer

2.36E-02

Cell Death and Survival

apoptosis of lung cancer cell lines

3.13E-03

Cell Death and Survival

killing of cells

4.80E-03
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Abnormalities, Tissue Morphology
Cellular Development, Cellular Growth and Proliferation
Cell Death and Survival
Cellular Development, Hematological System Development
and Function, Hematopoiesis, Tissue Development
Antimicrobial Response, Inflammatory Response
Cancer, Organismal Injury and Abnormalities, Reproductive
System Disease
Carbohydrate Metabolism, Lipid Metabolism, Small
Molecule Biochemistry
Carbohydrate Metabolism, Lipid Metabolism, Molecular
Transport, Small Molecule Biochemistry
Cellular Response to Therapeutics
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size of infarct
cell proliferation of cervical cancer
cell lines
cell death of sarcoma cell lines

2.88E-03
9.37E-03
1.94E-02

differentiation of megakaryocytes

1.12E-05

antibacterial response

2.83E-03

invasive breast cancer

2.55E-02

synthesis of phosphatidic acid

8.21E-03

concentration of phosphatidic acid

1.21E-02

sensitivity of cells

1.40E-02

Cell Cycle, DNA Replication, Recombination, and Repair

DNA recombination

2.41E-02

Respiratory Disease

chronic pulmonary disease
cell cycle progression of fibroblast
cell lines
recombination of cells

2.60E-02

senescence of fibroblast cell lines

5.48E-03

abnormal morphology of tail

5.98E-03

Gene Expression
Cancer, Cell Death and Survival, Organismal Injury and
Abnormalities, Tumor Morphology
Cancer, Dermatological Diseases and Conditions, Organismal
Injury and Abnormalities
Cancer, Organismal Injury and Abnormalities, Tissue
Morphology
Cell Cycle

binding of NFkB binding site

7.70E-03

cell death of osteosarcoma cells

1.50E-02

papilloma

1.65E-02

quantity of tumor

2.46E-02

G2 phase of tumor cell lines

2.91E-02

DNA Replication, Recombination, and Repair
DNA Replication, Recombination, and Repair, Gene
Expression
Organismal Injury and Abnormalities, Tissue Morphology
Lipid Metabolism, Molecular Transport, Small Molecule
Biochemistry
Cell Cycle, DNA Replication, Recombination, and Repair
Dermatological Diseases and Conditions, Organismal Injury
and Abnormalities
Hereditary Disorder, Neurological Disease, Organismal Injury
and Abnormalities
Connective Tissue Development and Function, Tissue
Morphology
Cancer, Organismal Injury and Abnormalities

breakage of DNA

1.02E-03

methylation of DNA

5.14E-03

volume of lesion

6.06E-03

accumulation of triacylglycerol

1.36E-02

homologous recombination of cells

1.36E-02

hyperkeratosis

1.48E-02

spinocerebellar ataxia

1.60E-02

quantity of white adipose tissue

1.80E-02

tumorigenesis of benign tumor
abnormal morphology of
blastocyst

2.24E-02

Cell Cycle, Connective Tissue Development and Function
Cell Cycle, DNA Replication, Recombination, and Repair
Cell Cycle, Cellular Development, Connective Tissue
Development and Function
Organismal Development

Organismal Development

1.29E-03
5.00E-03

2.85E-02
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Canonical pathway analysis of metastasis susceptibility candidates
The core gene set was enriched for molecules associated with cell-cell and cell-matrix
interactions as well as motility and related downstream signaling pathways (Figure 4.6A). In
addition, in agreement with previous results126, aryl hydrocarbon receptor signaling was also
implicated, as well as glucocorticoid receptor signaling, inflammatory and other immunological
components.
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Figure 4.6 Pathway analysis of 338 identified genes
Canonical Pathway results of Ingenuity Pathway Analysis of the 338 core gene set. Relative
strength of the p value of pathway association is indicated by the shade of red, with the darker
red indicating a smaller p value. The range of p values observed is indicated at the top of the
figure.
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Metastasis associated genes predict patient prognosis
As stated previously, we have identified 743 genes over-expressed in metastatic 4T1 cells
and 338 metastasis susceptibility genes that potentially promote metastasis progression by
comparative analysis of cell lines and mouse strains, respectively. We then further identified 25
genes that are shared with these two gene lists: Anxa1, Arrdc1, Cldn6, Ctsw, Hist1h1b,
Hist1h2ab, Hist1h2bb, Hist1h2bc, Hist1h2be, Hist1h2bm, Hist1h2bp, Hspa1b, Il1a, Il1b, Incenp,
Nrarp, Ovol1, Pak6, Pmepa1, Procr, Rom1, Scd2, Tmem223, Tprn, Tubb4b. Almost all these
genes show trends towards poorer patient survival if they are amplified, consistently with
positive gene expression correlation with imcreased malignancy across 4T1 cell line series.
Among these genes Tmem223 was significantly associated with patient prognosis when the gene
was amplified (Figure 4.7 A, C). Other genes, such as Nrarp, trended, but were not significantly
likely due to the relatively low fraction of patients with gene amplification (Figure 4.7B, D).
These data are consistent, however, with the ability of this strategy to identify important
metastasis-associated genes that individually may contribute to poor prognosis in small
subgroups of at-risk breast cancer patients.
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A

C

B

D

Figure 4.7 Distinct chromatin interactions and survival analysis on identified metastasisassociated genes
(A) Chromatin interactions with Tmem223 gene in 4T1 cell series. The green line indicates gene
promoter. The red lines indicate enhancers.
(B) Survival analysis of Tmem223 in humanbreast cancer patients.
(C) Chromatin interaction with Nrarp gene in 4T1 cell series. The green line indicates gene
promoter. The red line indicates enhancer.
(D) Survival analysis of Nrarp in human breast cancer patients.
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4.4 Discussion
Metastasis remains a significant problem for the management of breast cancer. Mortality
can be attributed to metastatic disease and its sequelae, rather than the effects of the originating
primary tumor. However, despite the importance of this process for patient outcome, relatively
little is known regarding the events that drive the metastatic cascade. A major reason for this
ignorance is the difficulty of obtaining appropriate tissue samples to perform in-depth genomic
characterizations. Metastatic lesions are usually not surgically removed, and those that are
resected are usually confounded by treatment186 which may select for events associated with
therapy resistance rather metastasis formation. In addition, biopsies of metastatic lesions in
untreated patients at diagnosis often suffer from low tumor content187 or necrosis186. Furthermore,
most metastatic lesions are not accessible to biopsy and repeated biopsies of multiple lesions
within individuals increases patient morbidity. As an added challenge, since metastasis within
patients exhibit significant heterogeneity at both the biomarker188–190 and genomic levels191,192,
selective biopsies may not capture the full complexity of events associated with tumor
progression.
Intriguingly, analysis of patient samples to date has not provided convincing evidence for
the existence of metastasis driver genes193–196. This may be due to limited numbers of samples
screened. However, studies to date suggest relatively few new coding mutations in metastases
compared to the primary tumor, and no obvious recurrent mutations in genes or pathways have
yet been described. Current efforts to address the question of metastasis driver genes in human
cancer are underway, utilizing biopsy or archival materials (reviewed in197). These studies,
however, are limited to a relatively small number of pre-selected genes and will therefore not
have the ability to identify novel and/or unexpected events. Furthermore, these studies also do
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not address the role of non-coding events or epigenetic events that may underlie metastatic
ability.
Mouse models overcome many of these limitations and offer many advantages. (i) a
readily available, renewable resource of tissue enables additional technologies to be applied to a
genetically equivalent set of tissues over time; (ii) the ability to observe the full natural history of
metastatic development, which is not possible in human cancers due to surgical resection and
application of neo-adjuvant and adjuvant therapies; (iii) the existence of syngeneic allograft
models that can be utilized to rapidly directly test hypotheses generated from genomic
characterization; and (iv) sophisticated genetic engineering capacities allow examination of
hypotheses in whole animals, including factors that may function through somatic
microenvironmental effects rather than direct effects on tumor cells, an area of research that is
precluded in most human studies. Data generated from exploitation of animal models therefore
provide an important vehicle for hypothesis generation and testing that can subsequently be
examined and verified in more restrictive human experimental systems.
The core gene set of 338 genes are significantly enriched in metabolic, cell-cell contact
and immune functions. Consistent with previous studies126,195,198,199, small molecule agents
implicated from these analyses to impact these molecular processes were found to significantly
affect metastatic progression, both positively and negatively, in these model systems. If these
results are translatable into human patients, they might provide opportunities to complement
current adjuvant therapies to further decrease or delay the occurrence of metastatic disease.
The integrated strategy presented here provides a novel method to identify potentially
important genes within the metastatic cascade. Encouragingly, a number of the genes in this core
set have previously been associated with metastatic breast cancer, including Mta2185 and
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Brms1184. Further validation and characterization of additional genes within the core 338 gene
set will likely provide evidence for additional metastasis susceptibility genes and valuable clues
to the molecular mechanisms driving metastatic colonization.
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Chapter 5: Conclusions, limitations and future
directions

111

Dissertation

Jacqueline Jufen Zhu

Chapter 5
5.1 Summary of the findings
Chromatin interaction and genome structure have been widely studied to explore the
regulatory mechanism of gene transcription. However, still little is known about the role of
chromatin organization in cancer progression. In my thesis, I have characterized the chromatin
interaction in mammalian cells using different methods including super-resolution imaging and
high-throughput sequencing. Besides the visualization of chromatin loop, I also interrogated the
chromatin reorganization in breast cancer metastasis. Beyond, I integrated the chromatin
interaction with polymorphic BACh sites to identify metastasis susceptibility genes and network.
The chromatin looping was inferred by DNA sequencing data. However, nobody has ever
seen exactly how the chromatin loops into functionally regulatory interactions. We applied the
super-resolution microscopy iPALM to image the 3D structure of the distinct 13 kb chromatin
loop up to 20 nm resolution laterally and axially. Unexpectedly, we observed a complex looping
structure instead of a single chromatin loop inferred by ChIA-PET data. Though the structures of
six individual images are positively correlated with Hi-C data, the ultrastructure of each structure
is very different across cells, suggesting the heterogeneity of the chromatin looping that can
hardly be detected by sequencing methods.
As chromatin organization is associated with gene transcription and disease development.
We have characterized the chromatin interaction in mouse breast cancer cell lines harboring
differed metastatic potential to investigate the enhancer regulation in metastasis progression. By
comprehensive comparison of transcription, chromatin accessibility and chromatin interaction in
4T1 cell series, we identified metastasis-associated genes and enhancers. The enhancer
distribution on metastasis-associated genes revealed a delicate regulatory system that one gene
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can be regulated by multiple enhancers and one enhancer can also regulate multiple genes in
metastasis. The multi-tasking enhancers connecting with multiple metastasis-associated genes
were validated by CRISPR knockout to play important roles in regulating gene transcription and
metastatic phenotypes, providing potential candidates for therapeutics in breast cancer metastasis.
For breast cancer metastasis study, we further introduced mouse strains for genetic
screening to identify metastasis susceptibility associated SNPs. By integrating chromatin
accessibility and interaction with identified SNPs, we identified a core set of metastasis
susceptibility associated genes. This set of genes include not only previously identified genes but
also novel ones that associate with metastasis. Pathway analysis suggested a couple of canonical
signaling pathways involved in metastasis progress. Of them, glucocorticoid receptor pathway
was validated to promote metastasis by mouse implantation experiment resulting higher
metastasis potential treated with dexamethasone.
Taken together of breast cancer analysis in both mouse cell lines and mouse strains,
Tmem223 and Nrarp were identified to be associated with metastasis progression consistently.
The survival rate analysis in human breast cancer patient showed the alterations on Tmem223
and Nrarp led to poorer survival compared to no alterations, indicating the critical importance of
fundamental studies.
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5.2 Limitation of the studies
The super-resolution imaging on chromatin interaction provided novel insights into the
chromatin looping conformation. However, the structure of the chromatin interaction is not fully
unraveled due to the limitations of the methods. Firstly, DNA FISH used to stain the target
chromatin region including the loop and the tails is in single color so that we are not able to
distinguish the loop and the tails, giving more difficulties to the following modeling analysis.
Secondly, the penetration depth of iPALM microscopy is only 600 nm, which is theoretically
sufficient to cover the target chromatin region, but taking the whole nucleus into account, the
penetration depth might not be able to capture the intact target region. Thirdly, the DNA FISH
staining efficiency is not ideal to allow all the probe oligos to attach to the chromatin. Ideally, we
have 336 fluorophores in total to hybridized with the 33 kb DNA in a density of about 10
fluorophore/kb, which enables the detection of DNA with at least one fluorophore per
nucleosome. However, in fact we only got about 70 fluorophores in average for each copy of the
chromatin, decreasing the labeling density about five-fold. Lastly, due to the efficiency of
iPALM, limited images were acquired that might not fully reflect all the possible conformation
of the chromatin loop, which are not representative or conclusive enough.
In breast cancer metastasis study, we utilized the genetic screening for pairs of mouse
strains to identify metastasis susceptibility associated SNPs, and integrated the SNPs with
chromatin accessibility and interactions characterized in 4T1 mouse cell line series to identify
metastasis susceptibility associated genes. Due to the limitations and difficulties of ChIA-PET
technology and mouse strain cell collection, it is not realistic so far to characterize chromatin
interaction in mouse strains instead of cell lines. Though 4T1 cell line series are from tumors in
BALB/cJ mouse strain, the genetic background and genome organization of this in vitro model
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can be different from mouse strains studied in this thesis. Transcriptionally, 4T1 cell series are
triple negative; and the EMT is reversely correlated to metastasis, which is against the wellestablished metastasis mechanism, suggesting 4T1 model could possibly have a distinct
molecular mechanism regulating metastasis progression. Therefore, the transcription, chromatin
accessibility and interaction in mouse strains may not be fully recapitulated by the analysis of
4T1 cell lines.
In my study, I interrogate the chromatin interaction and gene regulation in mouse models.
To be more suggestive for understanding the mechanism in human and disease development,
similar strategies could be applied in human cell studies.
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5.3 Future directions
Regarding technologies used to study genome biology, high throughput DNA sequencing
leads an efficient way to study eukaryotic genome by capturing tons of pieces of chromatin
interactions. Despite the advantages, limitations are nonnegligible. Currently, sequencing
technologies characterize the genome of a cell population, so that we get an averaged or the most
frequently occurred chromatin conformation, which lacks individual specificity. Addressing the
genome organization of a single cell would be a trend in the future. Different from sequencing
technologies, imaging is a complementary method that allows investigation in single cell, but
with a shortcoming of low throughput. Besides the improvement in resolution, a high throughput
operation in visualizing chromatin conformation could be pursued.
In the aspect of biological significance of genome study, characterizing genome
organization in primary human cells would be more informative and suggestive for finding cures
to diseases. The future goal is to be able to dig out genome structure associated driving factors
for disease genesis in each patient individual if desired, and rescue the abnormality using
genome or epigenome editing tools.
In terms of the philosophy beyond biology, I have got inspired through my doctoral study.
I have been studying biology for 12 years, majoring in bio-engineering, microbiology and
medical sciences for bachelor, master and PhD, respectively. I like sciences, including math,
physics, chemistry, etc. Unlike the subjects that are quantitative, biology is hardly predictable
due to the nature of lives. “Life is like a box of chocolate, you never know what you’re gonna
get.” This is the most fun part for me, driving me to try to get closer to the truth of life. The
ultimate goal for me to study biology is to find the universal rules for the living organisms, to
answer the questions of who I am and where I am going. All the living organisms tend to live
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better by cooperation following certain rules. Microorganisms cooperate to let some of them to
evolve prior to the others. Cells in multicellular organisms cooperate to differentiate into
different parts. Nucleus and organelles cooperate within the cell to maintain cellular function.
Chromatin cooperate in the genome to regulate gene transcription. Even a slight change of the
chromatin organization could lead to a severely different result. More important to me, it is not to
cure diseases, not to understand the biology itself, but to find the balance and achieve the
harmony between the nature and the mankind.
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Appendices
DNA
RNA
ISH
FISH
CT
Chr
LAD
ICD
ESC
BAC
ChIP-seq
ATAC-seq
3C
4C
5C
Hi-C
ChIA-PET
H3K27ac
H3K4me3
2D
3D
DHS
BACh
TAD
CTCF
RNAPII
YY1
TALEN
CRISPR
STORM
PALM
iPALM
SIM
STED
lncRNA
Xist
Firre
Xi
Xa
ICF
T-ALL
SNP
CCD
TCRA

Deoxyribonucleic acid
Ribonucleic acid
In situ hybridization
Fluorescence in situ hybridization
Chromosome territory
Chromosome
Lamina-associated domain
Interchromosomal domain
Embryonic stem cell
Bacterial artificial chromosome
Chromatin immunoprecipitation sequencing
Transposase-accessible chromatin using sequencing
Chromosome conformation capture
Circular chromosome conformation capture
Chromosome conformation capture carbon copy
High-throughput chromosome conformation capture
Chromatin interaction analysis using pair-end tag sequencing
Histone 3 lysine 27 acetylation
Histone 3 lysine 4 trimethylation
Two-dimension
Three-dimension
DNase Hypersensitive site
Benzonase accessible chromatin
Topologically associating domain
CCCTC-binding factor
RNA polymerase II
Ying yang 1
Transcription activator-like effector nucleases
Clustered regularly interspaced short palindromic repeats
Stochastic optical reconstruction microscopy
Photoactivated localization microscopy
Interferometric Photoactivated localization microscopy
Structural illumination microscopy
Stimulated emission depletion
Long non-coding RNA
X-inactive specific transcript
Functional intergenic repeating RNA element
Inactive X chromosome
Active X chromosome
Instability facial anomalies
T-cell acute lymphoblastic leukemia
Single nucleotide polymorphism
CTCF-mediated chromatin contact domains
T-cell receptor alpha
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PBS
KOH
SSC
EMCCD
NN
NJ
TSP
TSS
qRT-PCR
HDR
H&E
PRC
ECDF
K-S test
EMT
PPAR
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Phosphate-buffered saline
Potassium hydroxide
Saline-sodium citrate
Electron-multiplying charge-coupled device
Nearest neighbor
Neighbor joining
Traveling salesman problem solver
Transcription start site
Quantitative reverse transcription polymerase chain reaction
Homology-directed repair
hematoxylin and eosin
Percent reference peak coverage
Empirical cumulative distribution
Kolmogorov-Smirnov test
Epithelial-to-mesenchymal transition
Peroxisome proliferator-activated receptor
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